RPS-BLAST 2.2.26 [Sep-21-2011]
Database: CDD.v3.10
44,354 sequences; 10,937,602 total letters
Searching..................................................done
Query= psy12232
(202 letters)
>gnl|CDD|107378 cd06383, PBP1_iGluR_AMPA_Like, N-terminal
leucine/isoleucine/valine-binding protein (LIVBP)-like
domain of uncharacterized AMPA-like receptors.
N-terminal leucine/isoleucine/valine-binding protein
(LIVBP)-like domain of uncharacterized AMPA-like
receptors. While this N-terminal domain belongs to the
periplasmic-binding fold type I superfamily, the
glutamate-binding domain of the iGluR is structurally
homologous to the periplasmic-binding fold type II. The
LIVBP-like domain of iGluRs is thought to play a role in
the initial assembly of iGluR subunits, but it is not
well understood how this domain is arranged and
functions in intact iGluR. AMPA receptors consist of
four types of subunits (GluR1, GluR2, GluR3, and GluR4)
which combine to form a tetramer and play an important
roles in mediating the rapid excitatory synaptic
current.
Length = 368
Score = 133 bits (337), Expect = 8e-38
Identities = 56/121 (46%), Positives = 73/121 (60%), Gaps = 2/121 (1%)
Query: 81 NLDGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYKSLLQNIPTR 140
+ YLIQ+ PP D + E IR I+ NIT+A IL+DD F+ DHKYKSLLQN PTR
Sbjct: 101 QEGDLEQPYLIQLMPPADDIVEAIRDIVSYYNITNAAILYDDDFVMDHKYKSLLQNWPTR 160
Query: 141 HIIAPVEDSRS-VKRQLFRFKDLDIVNYFILGRL-QTIKMILDSANVNKFFGRKFAWHAI 198
H+I + V+ Q+ R ++LDI N FILG + I+ +LD A F GRK+AW
Sbjct: 161 HVITIINSIIDEVREQIKRLRNLDIKNIFILGSTEEIIRYVLDQALAEGFMGRKYAWFLG 220
Query: 199 T 199
Sbjct: 221 N 221
>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine
Kinase, Fibroblast Growth Factor Receptor 3. Protein
Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
Receptor 3 (FGFR3); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. FGFR3 is
part of the FGFR subfamily, which are receptor tyr
kinases (RTKs) containing an extracellular
ligand-binding region with three immunoglobulin-like
domains, a transmembrane segment, and an intracellular
catalytic domain. The binding of FGFRs to their ligands,
the FGFs, results in receptor dimerization and
activation, and intracellular signaling. The binding of
FGFs to FGFRs is promiscuous, in that a receptor may be
activated by several ligands and a ligand may bind to
more that one type of receptor. Many FGFR3 splice
variants have been reported with the IIIb and IIIc
isoforms being the predominant forms. FGFR3 IIIc is the
isoform expressed in chondrocytes, the cells affected in
dwarfism, while IIIb is expressed in epithelial cells.
FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and
FGF23. It is a negative regulator of long bone growth.
In the cochlear duct and in the lens, FGFR3 is involved
in differentiation while it appears to have a role in
cell proliferation in epithelial cells. Germline
mutations in FGFR3 are associated with skeletal
disorders including several forms of dwarfism. Some
missense mutations are associated with multiple myeloma
and carcinomas of the bladder and cervix. Overexpression
of FGFR3 is found in thyroid carcinoma.
Length = 334
Score = 58.1 bits (140), Expect = 3e-10
Identities = 30/67 (44%), Positives = 37/67 (55%), Gaps = 9/67 (13%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPSSED--- 60
Y +MR+CW V S+RP F QLV LDR+LTVT+ + EYL+L P P D
Sbjct: 266 YMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTD----EYLDLSVPFEQYSPGCPDSPS 321
Query: 61 --ESNDD 65
S DD
Sbjct: 322 SCSSGDD 328
>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine
Kinase, Fibroblast Growth Factor Receptor 2. Protein
Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
Receptor 2 (FGFR2); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. FGFR2 is
part of the FGFR subfamily, which are receptor tyr
kinases (RTKs) containing an extracellular
ligand-binding region with three immunoglobulin-like
domains, a transmembrane segment, and an intracellular
catalytic domain. The binding of FGFRs to their ligands,
the FGFs, results in receptor dimerization and
activation, and intracellular signaling. The binding of
FGFs to FGFRs is promiscuous, in that a receptor may be
activated by several ligands and a ligand may bind to
more that one type of receptor. There are many splice
variants of FGFR2 which show differential expression and
binding to FGF ligands. Disruption of either FGFR2 or
FGFR2b is lethal in mice, due to defects in the placenta
or severe impairment of tissue development including
lung, limb, and thyroid, respectively. Disruption of
FGFR2c in mice results in defective bone and skull
development. Genetic alterations of FGFR2 are associated
with many human skeletal disorders including Apert
syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and
Pfeiffer syndrome.
Length = 304
Score = 52.7 bits (126), Expect = 2e-08
Identities = 22/35 (62%), Positives = 25/35 (71%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
Y +MRDCW + S RP F QLV LDRILT+T NE
Sbjct: 269 YMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTNE 303
>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine
Kinase, Fibroblast Growth Factor Receptor 1. Protein
Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
Receptor 1 (FGFR1); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. FGFR1 is
part of the FGFR subfamily, which are receptor tyr
kinases (RTKs) containing an extracellular
ligand-binding region with three immunoglobulin-like
domains, a transmembrane segment, and an intracellular
catalytic domain. The binding of FGFRs to their ligands,
the FGFs, results in receptor dimerization and
activation, and intracellular signaling. The binding of
FGFs to FGFRs is promiscuous, in that a receptor may be
activated by several ligands and a ligand may bind to
more that one type of receptor. Alternative splicing of
FGFR1 transcripts produces a variety of isoforms, which
are differentially expressed in cells. FGFR1 binds the
ligands, FGF1 and FGF2, with high affinity and has also
been reported to bind FGF4, FGF6, and FGF9. FGFR1
signaling is critical in the control of cell migration
during embryo development. It promotes cell
proliferation in fibroblasts. Nuclear FGFR1 plays a role
in the regulation of transcription. Mutations,
insertions or deletions of FGFR1 have been identified in
patients with Kallman's syndrome (KS), an inherited
disorder characterized by hypogonadotropic hypogonadism
and loss of olfaction. Aberrant FGFR1 expression has
been found in some human cancers including 8P11
myeloproliferative syndrome (EMS), breast cancer, and
pancreatic adenocarcinoma.
Length = 307
Score = 50.4 bits (120), Expect = 1e-07
Identities = 21/35 (60%), Positives = 26/35 (74%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRILTVTANE 38
Y +MRDCW V S+RP F QLV LDRIL +T+N+
Sbjct: 272 YMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSNQ 306
>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine
Kinase, Fibroblast Growth Factor Receptor 4. Protein
Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
Receptor 4 (FGFR4); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. FGFR4 is
part of the FGFR subfamily, which are receptor tyr
kinases (RTKs) containing an extracellular
ligand-binding region with three immunoglobulin-like
domains, a transmembrane segment, and an intracellular
catalytic domain. The binding of FGFRs to their ligands,
the FGFs, results in receptor dimerization and
activation, and intracellular signaling. The binding of
FGFs to FGFRs is promiscuous, in that a receptor may be
activated by several ligands and a ligand may bind to
more that one type of receptor. Unlike other FGFRs,
there is only one splice form of FGFR4. It binds FGF1,
FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective
ligand for FGFR4. Although disruption of FGFR4 in mice
causes no obvious phenotype, in vivo inhibition of FGFR4
in cultured skeletal muscle cells resulted in an arrest
of muscle progenitor differentiation. FGF6 and FGFR4 are
uniquely expressed in myofibers and satellite cells.
FGF6/FGFR4 signaling appears to play a key role in the
regulation of muscle regeneration. A polymorphism in
FGFR4 is found in head and neck squamous cell carcinoma.
Length = 314
Score = 48.8 bits (116), Expect = 4e-07
Identities = 23/54 (42%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYLGQEYLELEAPLLDTPPS 57
Y LMR+CW V ++RP F QLV LD++L + +EYL+L P PS
Sbjct: 266 YMLMRECWHAVPTQRPTFKQLVEALDKVLAA-----VSEEYLDLSMPFEQYSPS 314
>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine
Kinases, Fibroblast Growth Factor Receptors. Protein
Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
Receptor (FGFR) subfamily; catalytic (c) domain. The
FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4,
and similar proteins. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K).PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. FGFR subfamily members
are receptor tyr kinases (RTKs) containing an
extracellular ligand-binding region with three
immunoglobulin-like domains, a transmembrane segment,
and an intracellular catalytic domain. The binding of
FGFRs to their ligands, the FGFs, and to heparin/heparan
sulfate (HS) results in the formation of a ternary
complex, which leads to receptor dimerization and
activation, and intracellular signaling. There are at
least 23 FGFs and four types of FGFRs. The binding of
FGFs to FGFRs is promiscuous, in that a receptor may be
activated by several ligands and a ligand may bind to
more that one type of receptor. FGF/FGFR signaling is
important in the regulation of embryonic development,
homeostasis, and regenerative processes. Depending on
the cell type and stage, FGFR signaling produces diverse
cellular responses including proliferation, growth
arrest, differentiation, and apoptosis. Aberrant
signaling leads to many human diseases such as skeletal,
olfactory, and metabolic disorders, as well as cancer.
Length = 293
Score = 48.2 bits (115), Expect = 6e-07
Identities = 20/30 (66%), Positives = 22/30 (73%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRILT 33
Y LMRDCW V S+RP F QLV LDR+LT
Sbjct: 264 YHLMRDCWHEVPSQRPTFKQLVEDLDRMLT 293
>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein
Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family;
Ephrin Receptor (EphR) subfamily; catalytic (c) domain.
The PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. EphRs
comprise the largest subfamily of receptor tyr kinases
(RTKs). They can be classified into two classes (EphA
and EphB), according to their extracellular sequences,
which largely correspond to binding preferences for
either GPI-anchored ephrin-A ligands or transmembrane
ephrin-B ligands. Vertebrates have ten EphA and six EhpB
receptors, which display promiscuous ligand interactions
within each class. EphRs contain an ephrin binding
domain and two fibronectin repeats extracellularly, a
transmembrane segment, and a cytoplasmic tyr kinase
domain. Binding of the ephrin ligand to EphR requires
cell-cell contact since both are anchored to the plasma
membrane. This allows ephrin/EphR dimers to form,
leading to the activation of the intracellular tyr
kinase domain. The resulting downstream signals occur
bidirectionally in both EphR-expressing cells (forward
signaling) and ephrin-expressing cells (reverse
signaling). The main effect of ephrin/EphR interaction
is cell-cell repulsion or adhesion. Ephrin/EphR
signaling is important in neural development and
plasticity, cell morphogenesis and proliferation,
cell-fate determination, embryonic development, tissue
patterning, and angiogenesis.
Length = 266
Score = 43.5 bits (103), Expect = 3e-05
Identities = 15/29 (51%), Positives = 21/29 (72%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
Y+LM DCW +ERP F Q+VS LD+++
Sbjct: 238 YQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
>gnl|CDD|107346 cd06351, PBP1_iGluR_N_LIVBP_like, N-terminal
leucine/isoleucine/valine-binding protein (LIVBP)-like
domain of the NMDA, AMPA, and kainate receptor subtypes
of ionotropic glutamate receptors (iGluRs). N-terminal
leucine/isoleucine/valine-binding protein (LIVBP)-like
domain of the NMDA, AMPA, and kainate receptor subtypes
of ionotropic glutamate receptors (iGluRs). While this
N-terminal domain belongs to the periplasmic-binding
fold type I superfamily, the glutamate-binding domain of
the iGluR is structurally homologous to the
periplasmic-binding fold type II. The LIVBP-like domain
of iGluRs is thought to play a role in the initial
assembly of iGluR subunits, but it is not well
understood how this domain is arranged and functions in
intact iGluR. Glutamate mediates the majority of
excitatory synaptic transmission in the central nervous
system via two broad classes of ionotropic receptors
characterized by their response to glutamate agonists:
N-methyl-aspartate (NMDA) and non-NMDA receptors. NMDA
receptors have intrinsically slow kinetics, are highly
permeable to Ca2+, and are blocked by extracellular Mg2+
in a voltage-dependent manner. On the other hand,
non-NMDA receptors have faster kinetics, are weakly
permeable to Ca2+, and are not blocked by extracellular
Mg2+. While non-NMDA receptors typically mediate
excitatory synaptic responses at resting membrane
potentials, NMDA receptors contribute to several forms
of synaptic plasticity and are suggested to play an
important role in the development of synaptic pathways.
Length = 328
Score = 42.9 bits (101), Expect = 4e-05
Identities = 30/155 (19%), Positives = 54/155 (34%), Gaps = 19/155 (12%)
Query: 55 PPSSEDESNDDEETCAYLLESVIRIS-----NLDGEQMKYLIQVNPPGDILPEVIRAIIL 109
P+S + ++ + C L I IS D E+ +Q+ P + L + + ++
Sbjct: 69 GPTSSESASAVQSICDALEIPHISISGGSEGLSDKEESSTTLQLYPSLEDLADALLDLLE 128
Query: 110 MQNITDAGILFDDSFIFDHKYKSLLQNIPTRHIIAP-------VEDSRSVKRQLFR-FKD 161
N T I++D S LQ + I ++ RQL + K
Sbjct: 129 YYNWTKFAIIYDSDE-----GLSRLQELLDESGIKGIQVTVRRLDLDDDNYRQLLKELKR 183
Query: 162 LDIVNYFILG-RLQTIKMILDSANVNKFFGRKFAW 195
+ + + K IL+ A G + W
Sbjct: 184 SESRRIILDCSSEEEAKEILEQAVELGMMGYGYHW 218
>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases.
Protein Tyrosine Kinase (PTK) family, catalytic domain.
This PTKc family is part of a larger superfamily that
includes the catalytic domains of protein
serine/threonine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase (PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. They can be classified
into receptor and non-receptor tyr kinases. PTKs play
important roles in many cellular processes including,
lymphocyte activation, epithelium growth and
maintenance, metabolism control, organogenesis
regulation, survival, proliferation, differentiation,
migration, adhesion, motility, and morphogenesis.
Receptor tyr kinases (RTKs) are integral membrane
proteins which contain an extracellular ligand-binding
region, a transmembrane segment, and an intracellular
tyr kinase domain. RTKs are usually activated through
ligand binding, which causes dimerization and
autophosphorylation of the intracellular tyr kinase
catalytic domain, leading to intracellular signaling.
Some RTKs are orphan receptors with no known ligands.
Non-receptor (or cytoplasmic) tyr kinases are
distributed in different intracellular compartments and
are usually multi-domain proteins containing a catalytic
tyr kinase domain as well as various regulatory domains
such as SH3 and SH2. PTKs are usually autoinhibited and
require a mechanism for activation. In many PTKs, the
phosphorylation of tyr residues in the activation loop
is essential for optimal activity. Aberrant expression
of PTKs is associated with many development
abnormalities and cancers.
Length = 262
Score = 41.4 bits (98), Expect = 1e-04
Identities = 12/26 (46%), Positives = 16/26 (61%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLD 29
YELM CW +RP F +LV +L+
Sbjct: 237 YELMLSCWQLDPEDRPTFSELVERLE 262
>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase.
Length = 258
Score = 39.4 bits (93), Expect = 5e-04
Identities = 13/25 (52%), Positives = 16/25 (64%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKL 28
YELM CW+Y +RP F +LV L
Sbjct: 234 YELMLQCWAYDPEDRPTFSELVEDL 258
>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain.
Phosphotransferases. Tyrosine-specific kinase subfamily.
Length = 257
Score = 39.4 bits (93), Expect = 6e-04
Identities = 11/25 (44%), Positives = 15/25 (60%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKL 28
Y+LM CW+ +RP F +LV L
Sbjct: 233 YDLMLQCWAEDPEDRPTFSELVEIL 257
>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase,
Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK)
family; Focal Adhesion Kinase (FAK); catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. FAK is a
cytoplasmic (or nonreceptor) tyr kinase that contains an
autophosphorylation site and a FERM domain at the
N-terminus, a central tyr kinase domain, proline-rich
regions, and a C-terminal FAT (focal adhesion targeting)
domain. FAK activity is dependent on integrin-mediated
cell adhesion, which facilitates N-terminal
autophosphorylation. Full activation is achieved by the
phosphorylation of its two adjacent A-loop tyrosines.
FAK is important in mediating signaling initiated at
sites of cell adhesions and at growth factor receptors.
Through diverse molecular interactions, FAK functions as
a biosensor or integrator to control cell motility. It
is a key regulator of cell survival, proliferation,
migration and invasion, and thus plays an important role
in the development and progression of cancer. Src binds
to autophosphorylated FAK forming the FAK-Src dual
kinase complex, which is activated in a wide variety of
tumor cells and generates signals promoting growth and
metastasis. FAK is being developed as a target for
cancer therapy.
Length = 270
Score = 39.3 bits (92), Expect = 6e-04
Identities = 14/29 (48%), Positives = 19/29 (65%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
Y LM CW+Y S+RP F +L ++L IL
Sbjct: 238 YSLMTKCWAYDPSKRPRFTELKAQLSDIL 266
>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity.
Phosphotransferases. The specificity of this class of
kinases can not be predicted. Possible dual-specificity
Ser/Thr/Tyr kinase.
Length = 258
Score = 38.3 bits (90), Expect = 0.001
Identities = 11/25 (44%), Positives = 15/25 (60%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKL 28
Y+LM CW+ +RP F +LV L
Sbjct: 234 YKLMLQCWAEDPEDRPTFSELVEIL 258
>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine
Kinases, Class EphA Ephrin Receptors. Protein Tyrosine
Kinase (PTK) family; Ephrin Receptor (EphR) subfamily;
most class EphA receptors including EphA3, EphA4, EphA5,
and EphA7, but excluding EphA1, EphA2 and EphA10;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. EphRs comprise the
largest subfamily of receptor tyr kinases (RTKs). In
general, class EphA receptors bind GPI-anchored ephrin-A
ligands. There are ten vertebrate EphA receptors
(EphA1-10), which display promiscuous interactions with
six ephrin-A ligands. One exception is EphA4, which also
binds ephrins-B2/B3. EphRs contain an ephrin-binding
domain and two fibronectin repeats extracellularly, a
transmembrane segment, and a cytoplasmic tyr kinase
domain. Binding of the ephrin ligand to EphR requires
cell-cell contact since both are anchored to the plasma
membrane. The resulting downstream signals occur
bidirectionally in both EphR-expressing cells (forward
signaling) and ephrin-expressing cells (reverse
signaling). Ephrin/EphR interaction mainly results in
cell-cell repulsion or adhesion, making it important in
neural development and plasticity, cell morphogenesis,
cell-fate determination, embryonic development, tissue
patterning, and angiogenesis. EphARs and ephrin-A
ligands are expressed in multiple areas of the
developing brain, especially in the retina and tectum.
They are part of a system controlling retinotectal
mapping.
Length = 267
Score = 38.3 bits (89), Expect = 0.001
Identities = 14/29 (48%), Positives = 22/29 (75%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
++LM DCW +ERP+F Q+VS LD+++
Sbjct: 239 HQLMLDCWQKDRNERPKFEQIVSILDKLI 267
>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like
Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK)
family; Insulin Receptor (InsR) subfamily; catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). The InsR subfamily
is composed of InsR, Insulin-like Growth Factor-1
Receptor (IGF-1R), and similar proteins. PTKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. InsR and
IGF-1R are receptor tyr kinases (RTKs) composed of two
alphabeta heterodimers. Binding of the ligand (insulin,
IGF-1, or IGF-2) to the extracellular alpha subunit
activates the intracellular tyr kinase domain of the
transmembrane beta subunit. Receptor activation leads to
autophosphorylation, stimulating downstream kinase
activities, which initiate signaling cascades and
biological function. InsR and IGF-1R, which share 84%
sequence identity in their kinase domains, display
physiologically distinct yet overlapping functions in
cell growth, differentiation, and metabolism. InsR
activation leads primarily to metabolic effects while
IGF-1R activation stimulates mitogenic pathways. In
cells expressing both receptors, InsR/IGF-1R hybrids are
found together with classical receptors. Both receptors
can interact with common adaptor molecules such as IRS-1
and IRS-2.
Length = 277
Score = 37.7 bits (88), Expect = 0.002
Identities = 13/27 (48%), Positives = 16/27 (59%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDR 30
ELMR CW Y RP F+++VS L
Sbjct: 251 LELMRMCWQYNPKMRPTFLEIVSSLKD 277
>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src
kinase-like Protein Tyrosine Kinases. Protein Tyrosine
Kinase (PTK) family; C-terminal Src kinase (Csk)
subfamily; catalytic (c) domain. The Csk subfamily is
composed of Csk, Chk, and similar proteins. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Csk
subfamily kinases are cytoplasmic (or nonreceptor) tyr
kinases containing the Src homology domains, SH3 and
SH2, N-terminal to the catalytic tyr kinase domain. They
negatively regulate the activity of Src kinases that are
anchored to the plasma membrane. To inhibit Src kinases,
Csk and Chk are translocated to the membrane via binding
to specific transmembrane proteins, G-proteins, or
adaptor proteins near the membrane. Csk catalyzes the
tyr phosphorylation of the regulatory C-terminal tail of
Src kinases, resulting in their inactivation. Chk
inhibit Src kinases using a noncatalytic mechanism by
simply binding to them. As negative regulators of Src
kinases, Csk and Chk play important roles in cell
proliferation, survival, and differentiation, and
consequently, in cancer development and progression.
Length = 256
Score = 37.0 bits (86), Expect = 0.003
Identities = 12/28 (42%), Positives = 18/28 (64%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRI 31
Y++M+DCW ++RP F QL +L I
Sbjct: 229 YKVMKDCWELDPAKRPTFKQLREQLALI 256
>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein
Tyrosine Kinases, Janus kinases. Protein Tyrosine
Kinase (PTK) family; Janus kinase (Jak) subfamily;
catalytic (c) domain (repeat 2). The Jak subfamily is
composed of Jak1, Jak2, Jak3, TYK2, and similar
proteins. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
Jak subfamily proteins are cytoplasmic (or nonreceptor)
tyr kinases containing an N-terminal FERM domain,
followed by a Src homology 2 (SH2) domain, a
pseudokinase domain, and a C-terminal tyr kinase
catalytic domain. Most Jaks are expressed in a wide
variety of tissues, except for Jak3, which is expressed
only in hematopoietic cells. Jaks are crucial for
cytokine receptor signaling. They are activated by
autophosphorylation upon cytokine-induced receptor
aggregation, and subsequently trigger downstream
signaling events such as the phosphorylation of signal
transducers and activators of transcription (STATs).
Jaks are also involved in regulating the surface
expression of some cytokine receptors. The Jak-STAT
pathway is involved in many biological processes
including hematopoiesis, immunoregulation, host defense,
fertility, lactation, growth, and embryogenesis.
Length = 284
Score = 37.0 bits (86), Expect = 0.004
Identities = 11/29 (37%), Positives = 17/29 (58%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
Y+LM+ CW +RP F L+ +DR+
Sbjct: 256 YDLMKLCWEAEPQDRPSFADLILIVDRLR 284
>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine
Kinase, Tie2. Protein Tyrosine Kinase (PTK) family;
Tie2; catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Tie2 is a receptor tyr
kinase (RTK) containing an extracellular region, a
transmembrane segment, and an intracellular catalytic
domain. The extracellular region contains an
immunoglobulin (Ig)-like domain, three epidermal growth
factor (EGF)-like domains, a second Ig-like domain, and
three fibronectin type III repeats. Tie2 is expressed
mainly in endothelial cells and hematopoietic stem
cells. It is also found in a subset of tumor-associated
monocytes and eosinophils. The angiopoietins (Ang-1 to
Ang-4) serve as ligands for Tie2. The binding of Ang-1
to Tie2 leads to receptor autophosphorylation and
activation, promoting cell migration and survival. In
contrast, Ang-2 binding to Tie2 does not result in the
same response, suggesting that Ang-2 may function as an
antagonist. Tie2 signaling plays key regulatory roles in
vascular integrity and quiescence, and in inflammation.
Length = 303
Score = 36.1 bits (83), Expect = 0.007
Identities = 14/29 (48%), Positives = 19/29 (65%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
Y+LMR CW ERP F Q++ L+R+L
Sbjct: 253 YDLMRQCWREKPYERPSFAQILVSLNRML 281
>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine
Kinases, Met and Ron. Protein Tyrosine Kinase (PTK)
family; Met and Ron; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Met and
Ron are receptor tyr kinases (RTKs) composed of an
alpha-beta heterodimer. The extracellular alpha chain is
disulfide linked to the beta chain, which contains an
extracellular ligand-binding region with a sema domain,
a PSI domain and four IPT repeats, a transmembrane
segment, and an intracellular catalytic domain. Binding
to their ligands leads to receptor dimerization,
autophosphorylation, activation, and intracellular
signaling. Met binds to the ligand, hepatocyte growth
factor/scatter factor (HGF/SF), and is also called the
HGF receptor. HGF/Met signaling plays a role in growth,
transformation, cell motility, invasion, metastasis,
angiogenesis, wound healing, and tissue regeneration.
Aberrant expression of Met through mutations or gene
amplification is associated with many human cancers
including hereditary papillary renal and gastric
carcinomas. The ligand for Ron is macrophage stimulating
protein (MSP). Ron signaling is important in regulating
cell motility, adhesion, proliferation, and apoptosis.
Aberrant Ron expression is implicated in tumorigenesis
and metastasis.
Length = 262
Score = 35.9 bits (83), Expect = 0.008
Identities = 12/29 (41%), Positives = 18/29 (62%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
YE+M CW RP F +LVS++++I
Sbjct: 232 YEVMLSCWHPKPEMRPTFSELVSRIEQIF 260
>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine
Kinases. Protein Tyrosine Kinase (PTK) family; Tie
subfamily; catalytic (c) domain. The Tie subfamily
consists of Tie1 and Tie2. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Tie proteins are
receptor tyr kinases (RTKs) containing an extracellular
region, a transmembrane segment, and an intracellular
catalytic domain. The extracellular region contains an
immunoglobulin (Ig)-like domain, three epidermal growth
factor (EGF)-like domains, a second Ig-like domain, and
three fibronectin type III repeats. Tie receptors are
specifically expressed in endothelial cells and
hematopoietic stem cells. The angiopoietins (Ang-1 to
Ang-4) serve as ligands for Tie2, while no specific
ligand has been identified for Tie1. The binding of
Ang-1 to Tie2 leads to receptor autophosphorylation and
activation, promoting cell migration and survival. In
contrast, Ang-2 binding to Tie2 does not result in the
same response, suggesting that Ang-2 may function as an
antagonist. In vivo studies of Tie1 show that it is
critical in vascular development.
Length = 270
Score = 35.8 bits (82), Expect = 0.008
Identities = 14/29 (48%), Positives = 19/29 (65%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
Y+LMR CW ERP F Q++ L+R+L
Sbjct: 241 YDLMRQCWREKPYERPSFAQILVSLNRML 269
>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine
Kinase-like Protein Tyrosine Kinases. Protein Tyrosine
Kinase (PTK) family; Spleen Tyrosine Kinase (Syk)
subfamily; catalytic (c) domain. The Syk subfamily is
composed of Syk, ZAP-70, Shark, and similar proteins.
The PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Syk
subfamily kinases are cytoplasmic (or nonreceptor) tyr
kinases containing two Src homology 2 (SH2) domains
N-terminal to the catalytic tyr kinase domain. They are
involved in the signaling downstream of activated
receptors (including B-cell, T-cell, and Fc receptors)
that contain ITAMs (immunoreceptor tyr activation
motifs), leading to processes such as cell
proliferation, differentiation, survival, adhesion,
migration, and phagocytosis. Syk is important in B-cell
receptor (BCR) signaling, while Zap-70 is primarily
expressed in T-cells and NK cells, and is a crucial
component in T-cell receptor (TCR) signaling. Syk also
plays a central role in Fc receptor-mediated
phagocytosis in the adaptive immune system. Shark is
exclusively expressed in ectodermally derived epithelia,
and is localized preferentially to the apical surface of
the epithelial cells, it may play a role in a signaling
pathway for epithelial cell polarity.
Length = 257
Score = 35.0 bits (81), Expect = 0.015
Identities = 11/29 (37%), Positives = 14/29 (48%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
Y +M CW Y +RP F +L S R
Sbjct: 228 YSIMLSCWKYRPEDRPTFSELESTFRRDP 256
>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine
Kinase, Tie1. Protein Tyrosine Kinase (PTK) family;
Tie1; catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Tie1 is a receptor tyr
kinase (RTK) containing an extracellular region, a
transmembrane segment, and an intracellular catalytic
domain. The extracellular region contains an
immunoglobulin (Ig)-like domain, three epidermal growth
factor (EGF)-like domains, a second Ig-like domain, and
three fibronectin type III repeats. Tie receptors are
specifically expressed in endothelial cells and
hematopoietic stem cells. No specific ligand has been
identified for Tie1, although the angiopoietin, Ang-1,
binds to Tie1 through integrins at high concentrations.
In vivo studies of Tie1 show that it is critical in
vascular development.
Length = 297
Score = 35.0 bits (80), Expect = 0.019
Identities = 15/29 (51%), Positives = 18/29 (62%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
YELMR CW ERP F Q+ +L R+L
Sbjct: 248 YELMRQCWRDRPYERPPFAQISVQLSRML 276
>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine
Kinases, Class EphB Ephrin Receptors. Protein Tyrosine
Kinase (PTK) family; Ephrin Receptor (EphR) subfamily;
class EphB receptors; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. EphRs
comprise the largest subfamily of receptor tyr kinases
(RTKs). Class EphB receptors bind to transmembrane
ephrin-B ligands. There are six vertebrate EhpB
receptors (EphB1-6), which display promiscuous
interactions with three ephrin-B ligands. One exception
is EphB2, which also interacts with ephrin A5. EphRs
contain an ephrin-binding domain and two fibronectin
repeats extracellularly, a transmembrane segment, and a
cytoplasmic tyr kinase domain. Binding of the ephrin
ligand to EphR requires cell-cell contact since both are
anchored to the plasma membrane. The resulting
downstream signals occur bidirectionally in both
EphR-expressing cells (forward signaling) and
ephrin-expressing cells (reverse signaling). Ephrin/EphR
interaction mainly results in cell-cell repulsion or
adhesion. EphBRs play important roles in synapse
formation and plasticity, spine morphogenesis, axon
guidance, and angiogenesis. In the intestinal
epithelium, EphBRs are Wnt signaling target genes that
control cell compartmentalization. They function as
suppressors of color cancer progression.
Length = 269
Score = 34.5 bits (79), Expect = 0.021
Identities = 13/29 (44%), Positives = 21/29 (72%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
++LM DCW + RP+F Q+VS LD+++
Sbjct: 241 HQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine
Kinases, Anaplastic Lymphoma Kinase and Leukocyte
Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family;
Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine
(tyr) Kinase (LTK); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to tyr
residues in protein substrates. ALK and LTK are orphan
receptor tyr kinases (RTKs) whose ligands are not yet
well-defined. RTKs contain an extracellular
ligand-binding domain, a transmembrane region, and an
intracellular tyr kinase domain. They are usually
activated through ligand binding, which causes
dimerization and autophosphorylation of the
intracellular tyr kinase catalytic domain. ALK appears
to play an important role in mammalian neural
development as well as visceral muscle differentiation
in Drosophila. ALK is aberrantly expressed as fusion
proteins, due to chromosomal translocations, in about
60% of anaplastic large cell lymphomas (ALCLs). ALK
fusion proteins are also found in rare cases of diffuse
large B cell lymphomas (DLBCLs). LTK is mainly expressed
in B lymphocytes and neuronal tissues. It is important
in cell proliferation and survival. Transgenic mice
expressing TLK display retarded growth and high
mortality rate. In addition, a polymorphism in mouse and
human LTK is implicated in the pathogenesis of systemic
lupus erythematosus.
Length = 277
Score = 34.3 bits (79), Expect = 0.024
Identities = 8/25 (32%), Positives = 15/25 (60%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKL 28
Y +M DCW + +RP F ++ ++
Sbjct: 251 YRIMTDCWQHTPEDRPNFATILERI 275
>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine
Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK)
family; Src-related kinase lacking C-terminal regulatory
tyrosine and N-terminal myristylation sites (Srm) and
breast tumor kinase (Brk, also called protein tyrosine
kinase 6); catalytic (c) domains. The PTKc family is
part of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Srm and
Brk are a member of the Src subfamily of proteins, which
are cytoplasmic (or non-receptor) tyr kinases. Src
kinases in general contain an N-terminal SH4 domain with
a myristoylation site, followed by SH3 and SH2 domains,
a tyr kinase domain, and a regulatory C-terminal region
containing a conserved tyr; they are activated by
autophosphorylation at the tyr kinase domain, but are
negatively regulated by phosphorylation at the
C-terminal tyr by Csk (C-terminal Src Kinase). Srm and
Brk however, lack the N-terminal myristylation sites.
Src proteins are involved in signaling pathways that
regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. Brk has been found to be overexpressed
in a majority of breast tumors.
Length = 261
Score = 34.3 bits (79), Expect = 0.026
Identities = 11/28 (39%), Positives = 17/28 (60%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRI 31
Y++M +CW+ +RP F L +LD I
Sbjct: 234 YKIMLECWAAEPEDRPSFKALREELDNI 261
>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine
Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase
(PTK) family; Ephrin Receptor (EphR) subfamily; EphA2
receptor; catalytic (c) domain. The PTKc family is part
of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. EphRs
comprise the largest subfamily of receptor tyr kinases
(RTKs). In general, class EphA receptors bind
GPI-anchored ephrin-A ligands. There are ten vertebrate
EphA receptors (EphA1-10), which display promiscuous
interactions with six ephrin-A ligands. EphRs contain an
ephrin binding domain and two fibronectin repeats
extracellularly, a transmembrane segment, and a
cytoplasmic tyr kinase domain. Binding of the ephrin
ligand to EphR requires cell-cell contact since both are
anchored to the plasma membrane. The resulting
downstream signals occur bidirectionally in both
EphR-expressing cells (forward signaling) and
ephrin-expressing cells (reverse signaling). Ephrin/EphR
interaction mainly results in cell-cell repulsion or
adhesion, making it important in neural development and
plasticity, cell morphogenesis, cell-fate determination,
embryonic development, tissue patterning, and
angiogenesis. The EphA2 receptor is overexpressed in
tumor cells and tumor blood vessels in a variety of
cancers including breast, prostate, lung, and colon. As
a result, it is an attractive target for drug design
since its inhibition could affect several aspects of
tumor progression.
Length = 268
Score = 34.2 bits (78), Expect = 0.031
Identities = 12/29 (41%), Positives = 19/29 (65%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
Y+LM CW + RP F+ +V+ LD++L
Sbjct: 240 YQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine
Kinase, Activated Cdc42-associated kinase. Protein
Tyrosine Kinase (PTK) family; Activated Cdc42-associated
kinase (Ack) subfamily; catalytic (c) domain. Ack
subfamily members include Ack1, thirty-eight-negative
kinase 1 (Tnk1), and similar proteins. The PTKc family
is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Ack
subfamily members are cytoplasmic (or nonreceptor) tyr
kinases containing an N-terminal catalytic domain, an
SH3 domain, a Cdc42-binding CRIB domain, and a
proline-rich region. They are mainly expressed in brain
and skeletal tissues and are involved in the regulation
of cell adhesion and growth, receptor degradation, and
axonal guidance. Ack1 is also associated with
androgen-independent prostate cancer progression. Tnk1
regulates TNFalpha signaling and may play an important
role in cell death.
Length = 257
Score = 33.9 bits (78), Expect = 0.036
Identities = 9/25 (36%), Positives = 14/25 (56%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKL 28
Y +M CW++ ++RP F L L
Sbjct: 231 YNVMLQCWAHNPADRPTFAALREFL 255
>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine
Kinase, Muscle-specific kinase. Protein Tyrosine Kinase
(PTK) family; Muscle-specific kinase (Musk); catalytic
(c) domain. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
Musk is a receptor tyr kinase (RTK) containing an
extracellular region with four immunoglobulin-like
domains and a cysteine-rich cluster, a transmembrane
segment, and an intracellular catalytic domain. Musk is
expressed and concentrated in the postsynaptic membrane
in skeletal muscle. It is essential for the
establishment of the neuromuscular junction (NMJ), a
peripheral synapse that conveys signals from motor
neurons to muscle cells. Agrin, a large proteoglycan
released from motor neurons, stimulates Musk
autophosphorylation and activation, leading to the
clustering of acetylcholine receptors (AChRs). To date,
there is no evidence to suggest that agrin binds
directly to Musk. Mutations in AChR, Musk and other
partners are responsible for diseases of the NMJ, such
as the autoimmune syndrome myasthenia gravis.
Length = 288
Score = 33.7 bits (77), Expect = 0.046
Identities = 13/27 (48%), Positives = 16/27 (59%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDR 30
Y LMR CWS + S+RP F + L R
Sbjct: 262 YNLMRLCWSKLPSDRPSFASINRILQR 288
>gnl|CDD|182343 PRK10262, PRK10262, thioredoxin reductase; Provisional.
Length = 321
Score = 33.5 bits (76), Expect = 0.051
Identities = 23/69 (33%), Positives = 33/69 (47%), Gaps = 3/69 (4%)
Query: 73 LESVIRISNLDGEQMKYLIQV-NPPGDILPEVIRAIILMQNITDAGILFDDSFIFDHKYK 131
L+ V+ G Q+ +V N PGD P + +LM+ + + F+ IFDH K
Sbjct: 30 LQPVLITGMEKGGQLTTTTEVENWPGD--PNDLTGPLLMERMHEHATKFETEIIFDHINK 87
Query: 132 SLLQNIPTR 140
LQN P R
Sbjct: 88 VDLQNRPFR 96
>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine
Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family;
Tyro3; catalytic (c) domain. The PTKc family is part of
a larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Tyro3 (or Sky) is a
member of the Axl subfamily, which is composed of
receptor tyr kinases (RTKs) containing an extracellular
ligand-binding region with two immunoglobulin-like
domains followed by two fibronectin type III repeats, a
transmembrane segment, and an intracellular catalytic
domain. Binding to their ligands, Gas6 and protein S,
leads to receptor dimerization, autophosphorylation,
activation, and intracellular signaling. Tyro3 is
predominantly expressed in the central nervous system
and the brain, and functions as a neurotrophic factor.
It is also expressed in osteoclasts and has a role in
bone resorption.
Length = 273
Score = 33.4 bits (76), Expect = 0.051
Identities = 13/29 (44%), Positives = 15/29 (51%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
YELM CWS RP F L +L+ I
Sbjct: 245 YELMCQCWSPEPKCRPSFQHLRDQLELIW 273
>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine
Kinase, Zeta-chain-associated protein of 70kDa. Protein
Tyrosine Kinase (PTK) family; Zeta-chain-associated
protein of 70kDa (Zap-70); catalytic (c) domain. The
PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Zap-70 is
a member of the Syk subfamily of kinases, which are
cytoplasmic (or nonreceptor) tyr kinases containing two
Src homology 2 (SH2) domains N-terminal to the catalytic
tyr kinase domain. Zap-70 is primarily expressed in
T-cells and NK cells, and is a crucial component in
T-cell receptor (TCR) signaling. Zap-70 binds the
phosphorylated ITAM (immunoreceptor tyr activation
motif) sequences of the activated TCR zeta-chain through
its SH2 domains, leading to its phosphorylation and
activation. It then phosphorylates target proteins,
which propagate the signals to downstream pathways.
Zap-70 is hardly detected in normal peripheral B-cells,
but is present in some B-cell malignancies. It is used
as a diagnostic marker for chronic lymphocytic leukemia
(CLL) as it is associated with the more aggressive
subtype of the disease.
Length = 257
Score = 33.4 bits (76), Expect = 0.051
Identities = 10/25 (40%), Positives = 16/25 (64%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKL 28
Y LM+DCW Y +RP F ++ ++
Sbjct: 228 YALMKDCWIYKWEDRPNFAKVEERM 252
>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase,
C-terminal Src kinase. Protein Tyrosine Kinase (PTK)
family; C-terminal Src kinase (Csk); catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. The Csk
subfamily kinases are cytoplasmic (or nonreceptor) tyr
kinases containing the Src homology domains, SH3 and
SH2, N-terminal to the catalytic tyr kinase domain. They
negatively regulate the activity of Src kinases that are
anchored to the plasma membrane. To inhibit Src kinases,
Csk is translocated to the membrane via binding to
specific transmembrane proteins, G-proteins, or adaptor
proteins near the membrane. Csk catalyzes the tyr
phosphorylation of the regulatory C-terminal tail of Src
kinases, resulting in their inactivation. Csk is
expressed in a wide variety of tissues. As a negative
regulator of Src, Csk plays a role in cell
proliferation, survival, and differentiation, and
consequently, in cancer development and progression. In
addition, Csk also shows Src-independent functions. It
is a critical component in G-protein signaling, and
plays a role in cytoskeletal reorganization and cell
migration.
Length = 256
Score = 33.4 bits (76), Expect = 0.057
Identities = 12/28 (42%), Positives = 19/28 (67%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRI 31
Y++M+ CW A+ RP F+QL +L+ I
Sbjct: 229 YDVMKQCWHLDAATRPSFLQLREQLEHI 256
>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase,
Abelson kinase. Protein Tyrosine Kinase (PTK) family;
Abelson (Abl) kinase; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Abl (or
c-Abl) is a ubiquitously-expressed cytoplasmic (or
nonreceptor) tyr kinase that contains SH3, SH2, and tyr
kinase domains in its N-terminal region, as well as
nuclear localization motifs, a putative DNA-binding
domain, and F- and G-actin binding domains in its
C-terminal tail. It also contains a short autoinhibitory
cap region in its N-terminus. Abl is normally inactive
and requires phosphorylation and myristoylation for
activation. Abl function depends on its subcellular
localization. In the cytoplasm, Abl plays a role in cell
proliferation and survival. In response to DNA damage or
oxidative stress, Abl is transported to the nucleus
where it induces apoptosis. In chronic myelogenous
leukemia (CML) patients, an aberrant translocation
results in the replacement of the first exon of Abl with
the BCR (breakpoint cluster region) gene. The resulting
BCR-Abl fusion protein is constitutively active and
associates into tetramers, resulting in a hyperactive
kinase sending a continuous signal. This leads to
uncontrolled proliferation, morphological transformation
and anti-apoptotic effects. BCR-Abl is the target of
selective inhibitors, such as imatinib (Gleevec), used
in the treatment of CML. Abl2, also known as ARG
(Abelson-related gene), is thought to play a cooperative
role with Abl in the proper development of the nervous
system. The Tel-ARG fusion protein, resulting from
reciprocal translocation between chromosomes 1 and 12,
is associated with acute myeloid leukemia (AML). The TEL
gene is a frequent fusion partner of other tyr kinase
oncogenes, including Tel/Abl, Tel/PDGFRbeta, and
Tel/Jak2, found in patients with leukemia and
myeloproliferative disorders.
Length = 263
Score = 33.3 bits (76), Expect = 0.060
Identities = 11/18 (61%), Positives = 13/18 (72%)
Query: 4 YELMRDCWSYVASERPEF 21
YELMR CW + S+RP F
Sbjct: 235 YELMRACWQWNPSDRPSF 252
>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein
Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family;
Tyrosine kinase expressed in hepatocellular carcinoma
(Tec) subfamily; catalytic (c) domain. The Tec subfamily
is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk
(Txk), and similar proteins. The PTKc family is part of
a larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Tec kinases are
cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with
similarity to Src kinases in that they contain Src
homology protein interaction domains (SH3, SH2)
N-terminal to the catalytic tyr kinase domain. Unlike
Src kinases, most Tec subfamily members (except Rlk)
also contain an N-terminal pleckstrin homology (PH)
domain, which binds the products of PI3K and allows
membrane recruitment and activation. In addition, some
members contain the Tec homology (TH) domain, which
contains proline-rich and zinc-binding regions. Tec
kinases form the second largest subfamily of nRTKs and
are expressed mainly by haematopoietic cells, although
Tec and Bmx are also found in endothelial cells. B-cells
express Btk and Tec, while T-cells express Itk, Txk, and
Tec. Collectively, Tec kinases are expressed in a
variety of myeloid cells such as mast cells, platelets,
macrophages, and dendritic cells. Each Tec kinase shows
a distinct cell-type pattern of expression. The function
of Tec kinases in lymphoid cells have been studied
extensively. They play important roles in the
development, differentiation, maturation, regulation,
survival, and function of B-cells and T-cells. Mutations
in Btk cause the severe B-cell immunodeficiency,
X-linked agammaglobulinaemia (XLA).
Length = 256
Score = 33.2 bits (76), Expect = 0.070
Identities = 10/28 (35%), Positives = 15/28 (53%)
Query: 1 MSSYELMRDCWSYVASERPEFIQLVSKL 28
Y +M CW +RP F +L+S+L
Sbjct: 228 TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine
Kinase, Insulin-like Growth Factor-1 Receptor. Protein
Tyrosine Kinase (PTK) family; Insulin-like Growth
Factor-1 Receptor (IGF-1R); catalytic (c) domain. The
PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. IGF-1R is
a receptor tyr kinases (RTK) that is composed of two
alphabeta heterodimers. Binding of the ligand (IGF-1 or
IGF-2) to the extracellular alpha subunit activates the
intracellular tyr kinase domain of the transmembrane
beta subunit. Receptor activation leads to
autophosphorylation, which stimulates downstream kinase
activities and biological function. IGF-1R signaling is
important in the differentiation, growth, and survival
of normal cells. In cancer cells, where it is frequently
overexpressed, IGF-1R is implicated in proliferation,
the suppression of apoptosis, invasion, and metastasis.
IGF-1R is being developed as a therapeutic target in
cancer treatment.
Length = 277
Score = 33.1 bits (75), Expect = 0.074
Identities = 11/25 (44%), Positives = 17/25 (68%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKL 28
+ELMR CW Y RP F++++S +
Sbjct: 251 FELMRMCWQYNPKMRPSFLEIISSI 275
>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein
Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family;
Src kinase subfamily; catalytic (c) domain. Src
subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr,
Fyn, Yrk, and Yes. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
Src (or c-Src) proteins are cytoplasmic (or
non-receptor) tyr kinases which are anchored to the
plasma membrane. They contain an N-terminal SH4 domain
with a myristoylation site, followed by SH3 and SH2
domains, a tyr kinase domain, and a regulatory
C-terminal region containing a conserved tyr. They are
activated by autophosphorylation at the tyr kinase
domain, but are negatively regulated by phosphorylation
at the C-terminal tyr by Csk (C-terminal Src Kinase).
Src proteins are involved in signaling pathways that
regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. They were identified as the first
proto-oncogene products, and they regulate cell
adhesion, invasion, and motility in cancer cells and
tumor vasculature, contributing to cancer progression
and metastasis. Src kinases are overexpressed in a
variety of human cancers, making them attractive targets
for therapy. They are also implicated in acute
inflammatory responses and osteoclast function. Src,
Fyn, Yes, and Yrk are widely expressed, while Blk, Lck,
Hck, Fgr, and Lyn show a limited expression pattern.
Length = 261
Score = 32.7 bits (75), Expect = 0.084
Identities = 12/26 (46%), Positives = 14/26 (53%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLD 29
Y+LM CW ERP F L S L+
Sbjct: 234 YDLMLQCWDKDPEERPTFEYLQSFLE 259
>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine
Kinase, Platelet Derived Growth Factor Receptor beta.
Protein Tyrosine Kinase (PTK) family; Platelet Derived
Growth Factor Receptor (PDGFR) beta; catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. PDGFR
beta is a receptor tyr kinase (RTK) containing an
extracellular ligand-binding region with five
immunoglobulin-like domains, a transmembrane segment,
and an intracellular catalytic domain. The binding to
its ligands, the PDGFs, leads to receptor dimerization,
trans phosphorylation and activation, and intracellular
signaling. PDGFR beta forms homodimers or heterodimers
with PDGFR alpha, depending on the nature of the PDGF
ligand. PDGF-BB and PDGF-DD induce PDGFR beta
homodimerization. PDGFR signaling plays many roles in
normal embryonic development and adult physiology. PDGFR
beta signaling leads to a variety of cellular effects
including the stimulation of cell growth and chemotaxis,
as well as the inhibition of apoptosis and GAP
junctional communication. It is critical in normal
angiogenesis as it is involved in the recruitment of
pericytes and smooth muscle cells essential for vessel
stability. Aberrant PDGFR beta expression is associated
with some human cancers. The continuously-active fusion
proteins of PDGFR beta with COL1A1 and TEL are
associated with dermatofibrosarcoma protuberans (DFSP)
and a subset of chronic myelomonocytic leukemia (CMML),
respectively.
Length = 401
Score = 33.1 bits (75), Expect = 0.092
Identities = 13/30 (43%), Positives = 18/30 (60%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRILT 33
YE+M+ CW RP+F QLV + +LT
Sbjct: 372 YEIMQKCWEEKFEIRPDFSQLVHLVGDLLT 401
>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine
Kinases, Discoidin Domain Receptors. Protein Tyrosine
Kinase (PTK) family; Discoidin Domain Receptor (DDR)
subfamily; catalytic (c) domain. The DDR subfamily
consists of homologs of mammalian DDR1, DDR2, and
similar proteins. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
DDR subfamily members are receptor tyr kinases (RTKs)
containing an extracellular discoidin homology domain, a
transmembrane segment, an extended juxtamembrane region,
and an intracellular catalytic domain. The binding of
the ligand, collagen, to DDRs results in a slow but
sustained receptor activation. DDRs regulate cell
adhesion, proliferation, and extracellular matrix
remodeling. They have been linked to a variety of human
cancers including breast, colon, ovarian, brain, and
lung. There is no evidence showing that DDRs act as
transforming oncogenes. They are more likely to play a
role in the regulation of tumor growth and metastasis.
Length = 296
Score = 32.7 bits (75), Expect = 0.10
Identities = 9/21 (42%), Positives = 13/21 (61%)
Query: 4 YELMRDCWSYVASERPEFIQL 24
YELM +CW +RP F ++
Sbjct: 270 YELMLECWRRDEEDRPTFREI 290
>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the
Protein Tyrosine Kinases, Janus kinases 2 and 3.
Protein Tyrosine Kinase (PTK) family; Janus kinase 2
(Jak2) and Jak3; catalytic (c) domain (repeat 2). The
PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Jak2 and
Jak3 are members of the Janus kinase (Jak) subfamily of
proteins, which are cytoplasmic (or nonreceptor) tyr
kinases containing an N-terminal FERM domain, followed
by a Src homology 2 (SH2) domain, a pseudokinase domain,
and a C-terminal catalytic tyr kinase domain. Jaks are
crucial for cytokine receptor signaling. They are
activated by autophosphorylation upon cytokine-induced
receptor aggregation, and subsequently trigger
downstream signaling events such as the phosphorylation
of signal transducers and activators of transcription
(STATs). Jak2 is widely expressed in many tissues while
Jak3 is expressed only in hematopoietic cells. Jak2 is
essential for the signaling of hormone-like cytokines
such as growth hormone, erythropoietin, thrombopoietin,
and prolactin, as well as some IFNs and cytokines that
signal through the IL-3 and gp130 receptors. Jak3 binds
the shared receptor subunit common gamma chain and thus,
is essential in the signaling of cytokines that use it
such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21.
Disruption of Jak2 in mice results in an embryonic
lethal phenotype with multiple defects including
erythropoietic and cardiac abnormalities. It is the only
Jak gene that results in a lethal phenotype when
disrupted in mice. A mutation in the pseudokinase domain
of Jak2, V617F, is present in many myeloproliferative
diseases, including almost all patients with
polycythemia vera, and 50% of patients with essential
thrombocytosis and myelofibrosis. Jak3 is important in
lymphoid development and myeloid cell differentiation.
Inactivating mutations in Jak3 have been reported in
humans with severe combined immunodeficiency (SCID).
Length = 284
Score = 32.4 bits (74), Expect = 0.10
Identities = 10/28 (35%), Positives = 19/28 (67%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRI 31
Y +M++CW+ S+RP F +L +++ I
Sbjct: 256 YAIMKECWNNDPSQRPSFSELALQVEAI 283
>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine
Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase
(PTK) family; Ephrin Receptor (EphR) subfamily; EphA10
receptor; catalytic (c) domain. The PTKc family is part
of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. EphRs
comprise the largest subfamily of receptor tyr kinases
(RTKs). In general, class EphA receptors bind
GPI-anchored ephrin-A ligands. There are ten vertebrate
EphA receptors (EphA1-10), which display promiscuous
interactions with six ephrin-A ligands. EphRs contain an
ephrin binding domain and two fibronectin repeats
extracellularly, a transmembrane segment, and a
cytoplasmic tyr kinase domain. Binding of the ephrin
ligand to EphR requires cell-cell contact since both are
anchored to the plasma membrane. The resulting
downstream signals occur bidirectionally in both
EphR-expressing cells (forward signaling) and
ephrin-expressing cells (reverse signaling). EphA10,
which contains an inactive tyr kinase domain, may
function to attenuate signals of co-clustered active
receptors. EphA10 is mainly expressed in the testis.
Ephrin/EphR interaction results in cell-cell repulsion
or adhesion, making it important in neural development
and plasticity, cell morphogenesis, cell-fate
determination, embryonic development, tissue patterning,
and angiogenesis.
Length = 266
Score = 32.6 bits (74), Expect = 0.11
Identities = 12/29 (41%), Positives = 18/29 (62%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
++LM DCW ERP F Q+ S L +++
Sbjct: 238 HQLMLDCWQKERGERPRFSQIHSILSKMV 266
>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine
Kinase, Vascular Endothelial Growth Factor Receptor 2.
Protein Tyrosine Kinase (PTK) family; Vascular
Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic
(c) domain. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
VEGFR2 (or Flk1) is a member of the VEGFR subfamily of
proteins, which are receptor tyr kinases (RTKs)
containing an extracellular ligand-binding region with
seven immunoglobulin (Ig)-like domains, a transmembrane
segment, and an intracellular catalytic domain. The
binding of VEGFRs to their ligands, the VEGFs, leads to
receptor dimerization, activation, and intracellular
signaling. The carboxyl terminus of VEGFR2 plays an
important role in its autophosphorylation and
activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD
and VEGFE. VEGFR2 signaling is implicated in all aspects
of normal and pathological vascular endothelial cell
biology. It induces a variety of cellular effects
including migration, survival, and proliferation. It is
critical in regulating embryonic vascular development
and angiogenesis. VEGFR2 is the major signal transducer
in pathological angiogenesis including cancer and
diabetic retinopathy, and is a target for inhibition in
cancer therapy.
Length = 343
Score = 32.3 bits (73), Expect = 0.13
Identities = 13/29 (44%), Positives = 17/29 (58%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
Y+ M DCW S+RP F +LV L +L
Sbjct: 312 YQTMLDCWHGEPSQRPTFSELVEHLGNLL 340
>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine
Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine
Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4);
pseudokinase domain. The PTKc (catalytic domain) family,
to which this subfamily belongs, includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. CCK4,
also called protein tyrosine kinase 7 (PTK7), is an
orphan receptor tyr kinase (RTK) containing an
extracellular region with seven immunoglobulin domains,
a transmembrane segment, and an intracellular inactive
pseudokinase domain. Studies in mice reveal that CCK4 is
essential for neural development. Mouse embryos
containing a truncated CCK4 die perinatally and display
craniorachischisis, a severe form of neural tube defect.
The mechanism of action of the CCK4 pseudokinase is
still unknown. Other pseudokinases such as HER3 rely on
the activity of partner RTKs.
Length = 275
Score = 31.7 bits (72), Expect = 0.18
Identities = 12/25 (48%), Positives = 16/25 (64%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKL 28
Y+LM CW+ +RP F +LVS L
Sbjct: 249 YKLMTRCWAVNPKDRPSFSELVSAL 273
>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein
Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family;
Axl subfamily; catalytic (c) domain. The PTKc family is
part of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). The Axl subfamily
consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and
similar proteins. PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Axl subfamily members
are receptor tyr kinases (RTKs) containing an
extracellular ligand-binding region with two
immunoglobulin-like domains followed by two fibronectin
type III repeats, a transmembrane segment, and an
intracellular catalytic domain. Binding to their
ligands, Gas6 and protein S, leads to receptor
dimerization, autophosphorylation, activation, and
intracellular signaling. Axl subfamily members are
implicated in a variety of cellular effects including
survival, proliferation, migration, and phagocytosis.
They are also associated with several types of cancer as
well as inflammatory, autoimmune, vascular, and kidney
diseases. Mer is named after its original reported
expression pattern (monocytes, epithelial, and
reproductive tissues). It is required for the ingestion
of apoptotic cells by phagocytes such as macrophages,
retinal pigment epithelial cells, and dendritic cells.
Mer is also important in maintaining immune homeostasis.
Length = 273
Score = 31.7 bits (72), Expect = 0.22
Identities = 12/29 (41%), Positives = 16/29 (55%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
Y+LM CW +RP F +L L+ IL
Sbjct: 245 YDLMYSCWRADPKDRPTFTKLREVLENIL 273
>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase,
Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Lyn is a member of the
Src subfamily of proteins, which are cytoplasmic (or
non-receptor) tyr kinases. Src kinases contain an
N-terminal SH4 domain with a myristoylation site,
followed by SH3 and SH2 domains, a tyr kinase domain,
and a regulatory C-terminal region containing a
conserved tyr. They are activated by autophosphorylation
at the tyr kinase domain, but are negatively regulated
by phosphorylation at the C-terminal tyr by Csk
(C-terminal Src Kinase). Src proteins are involved in
signaling pathways that regulate cytokine and growth
factor responses, cytoskeleton dynamics, cell
proliferation, survival, and differentiation. Lyn is
expressed in B lymphocytes and myeloid cells. It
exhibits both positive and negative regulatory roles in
B cell receptor (BCR) signaling. Lyn, as well as Fyn and
Blk, promotes B cell activation by phosphorylating ITAMs
(immunoreceptor tyr activation motifs) in CD19 and in Ig
components of BCR. It negatively regulates signaling by
its unique ability to phosphorylate ITIMs
(immunoreceptor tyr inhibition motifs) in cell surface
receptors like CD22 and CD5. Lyn also plays an important
role in G-CSF receptor signaling by phosphorylating a
variety of adaptor molecules.
Length = 261
Score = 31.1 bits (70), Expect = 0.28
Identities = 13/26 (50%), Positives = 16/26 (61%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLD 29
Y++M+ CW A ERP F L S LD
Sbjct: 234 YDIMKTCWKEKAEERPTFDYLQSVLD 259
>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to
tyrosine kinase). Protein Tyrosine Kinase (PTK) family;
Receptor related to tyrosine kinase (Ryk); pseudokinase
domain. The PTKc (catalytic domain) family to which this
subfamily belongs, is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Ryk is a
receptor tyr kinase (RTK) containing an extracellular
region with two leucine-rich motifs, a transmembrane
segment, and an intracellular inactive pseudokinase
domain. The extracellular region of Ryk shows homology
to the N-terminal domain of Wnt inhibitory factor-1
(WIF) and serves as the ligand (Wnt) binding domain of
Ryk. Ryk is expressed in many different tissues both
during development and in adults, suggesting a
widespread function. It acts as a chemorepulsive axon
guidance receptor of Wnt glycoproteins and is
responsible for the establishment of axon tracts during
the development of the central nervous system. In
addition, studies in mice reveal that Ryk is essential
in skeletal, craniofacial, and cardiac development.
Thus, it appears Ryk is involved in signal transduction
despite its lack of kinase activity. Ryk may function as
an accessory protein that modulates the signals coming
from catalytically active partner RTKs such as the Eph
receptors.
Length = 280
Score = 31.2 bits (71), Expect = 0.29
Identities = 11/25 (44%), Positives = 14/25 (56%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKL 28
+ +M CW+ ERP F QLV L
Sbjct: 249 FAVMACCWALDPEERPSFSQLVQCL 273
>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like
Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK)
family; Human Fyn-related kinase (Frk) and similar
proteins; catalytic (c) domain. The PTKc family is part
of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Frk and
Srk are members of the Src subfamily of proteins, which
are cytoplasmic (or non-receptor) tyr kinases. Src
kinases contain an N-terminal SH4 domain with a
myristoylation site, followed by SH3 and SH2 domains, a
tyr kinase domain, and a regulatory C-terminal region
containing a conserved tyr. They are activated by
autophosphorylation at the tyr kinase domain, but are
negatively regulated by phosphorylation at the
C-terminal tyr by Csk (C-terminal Src Kinase). Src
proteins are involved in signaling pathways that
regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. Frk, also known as Rak, is specifically
expressed in liver, lung, kidney, intestine, mammary
glands, and the islets of Langerhans. Rodent homologs
were previously referred to as GTK (gastrointestinal tyr
kinase), BSK (beta-cell Src-like kinase), or IYK
(intestinal tyr kinase). Studies in mice reveal that Frk
is not essential for viability. It plays a role in the
signaling that leads to cytokine-induced beta-cell death
in Type I diabetes. It also regulates beta-cell number
during embryogenesis and early in life.
Length = 261
Score = 31.2 bits (71), Expect = 0.31
Identities = 11/26 (42%), Positives = 15/26 (57%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLD 29
Y++M DCW +RP F L KL+
Sbjct: 234 YDIMLDCWKEDPDDRPTFETLQWKLE 259
>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase,
Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK)
family; Spleen tyrosine kinase (Syk); catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Syk,
together with Zap-70, form the Syk subfamily of kinases
which are cytoplasmic (or nonreceptor) tyr kinases
containing two Src homology 2 (SH2) domains N-terminal
to the catalytic tyr kinase domain. Syk was first cloned
from the spleen, and its function in hematopoietic cells
is well-established. Syk is involved in the signaling
downstream of activated receptors (including B-cell and
Fc receptors) that contain ITAMs (immunoreceptor tyr
activation motifs), leading to processes such as cell
proliferation, differentiation, survival, adhesion,
migration, and phagocytosis. More recently, Syk
expression has been detected in other cell types
(including epithelial cells, vascular endothelial cells,
neurons, hepatocytes, and melanocytes), suggesting a
variety of biological functions in non-immune cells. Syk
plays a critical role in maintaining vascular integrity
and in wound healing during embryogenesis. It also
regulates Vav3, which is important in osteoclast
function including bone development. In breast
epithelial cells, where Syk acts as a negative regulator
for epidermal growth factor receptor (EGFR) signaling,
loss of Syk expression is associated with abnormal
proliferation during cancer development suggesting a
potential role as a tumor suppressor. In mice, Syk has
been shown to inhibit malignant transformation of
mammary epithelial cells induced with murine mammary
tumor virus (MMTV).
Length = 257
Score = 31.1 bits (70), Expect = 0.31
Identities = 11/25 (44%), Positives = 16/25 (64%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKL 28
Y+LM+ CW+Y ERP F + +L
Sbjct: 228 YDLMKLCWTYGVDERPGFAVVELRL 252
>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase,
Axl. Protein Tyrosine Kinase (PTK) family; Axl;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Axl is a member of the
Axl subfamily, which is composed of receptor tyr kinases
(RTKs) containing an extracellular ligand-binding region
with two immunoglobulin-like domains followed by two
fibronectin type III repeats, a transmembrane segment,
and an intracellular catalytic domain. Binding to their
ligands, Gas6 and protein S, leads to receptor
dimerization, autophosphorylation, activation, and
intracellular signaling. Axl is widely expressed in a
variety of organs and cells including epithelial,
mesenchymal, hematopoietic, as well as non-transformed
cells. Axl signaling is important in many cellular
functions such as survival, anti-apoptosis,
proliferation, migration, and adhesion. Axl was
originally isolated from patients with chronic
myelogenous leukemia and a chronic myeloproliferative
disorder. Axl is overexpressed in many human cancers
including colon, squamous cell, thyroid, breast, and
lung carcinomas.
Length = 272
Score = 31.2 bits (70), Expect = 0.32
Identities = 11/29 (37%), Positives = 15/29 (51%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
Y LM CW +RP F L +L++ L
Sbjct: 244 YSLMSSCWLLNPKDRPSFETLRCELEKAL 272
>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine
Kinases, Vascular Endothelial Growth Factor Receptors.
Protein Tyrosine Kinase (PTK) family; Vascular
Endothelial Growth Factor Receptor (VEGFR) subfamily;
catalytic (c) domain. The VEGFR subfamily consists of
VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar
proteins. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
VEGFR subfamily members are receptor tyr kinases (RTKs)
containing an extracellular ligand-binding region with
seven immunoglobulin (Ig)-like domains, a transmembrane
segment, and an intracellular catalytic domain. In
VEGFR3, the fifth Ig-like domain is replaced by a
disulfide bridge. The binding of VEGFRs to their
ligands, the VEGFs, leads to receptor dimerization,
activation, and intracellular signaling. There are five
VEGF ligands in mammals, which bind, in an overlapping
pattern to the three VEGFRs, which can form homo or
heterodimers. VEGFRs regulate the cardiovascular system.
They are critical for vascular development during
embryogenesis and blood vessel formation in adults. They
induce cellular functions common to other growth factor
receptors such as cell migration, survival, and
proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta
growth factor (PLGF). It regulates monocyte and
macrophage migration, vascular permeability,
haematopoiesis, and the recruitment of haematopietic
progenitor cells from the bone marrow.
Length = 337
Score = 31.4 bits (71), Expect = 0.32
Identities = 12/29 (41%), Positives = 16/29 (55%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
Y +M DCW +RP F +LV L +L
Sbjct: 306 YSIMLDCWHNNPEDRPTFSELVEILGDLL 334
>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein
Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine
Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic
(c) domain (repeat 2). The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Tyk2 is a member of the
Janus kinase (Jak) subfamily of proteins, which are
cytoplasmic (or nonreceptor) tyr kinases containing an
N-terminal FERM domain, followed by a Src homology 2
(SH2) domain, a pseudokinase domain, and a C-terminal
tyr kinase catalytic domain. Jaks are crucial for
cytokine receptor signaling. They are activated by
autophosphorylation upon cytokine-induced receptor
aggregation, and subsequently trigger downstream
signaling events such as the phosphorylation of signal
transducers and activators of transcription (STATs).
Tyk2 is widely expressed in many tissues. It is involved
in signaling via the cytokine receptors IFN-alphabeta,
IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell
surface urokinase receptor (uPAR) signaling and plays a
role in modulating vascular smooth muscle cell (VSMC)
functional behavior in response to injury. Tyk2 is also
important in dendritic cell function and T helper (Th)1
cell differentiation. A homozygous mutation of Tyk2 was
found in a patient with hyper-IgE syndrome (HIES), a
primary immunodeficiency characterized by recurrent skin
abscesses, pneumonia, and elevated serum IgE. This
suggests that Tyk2 may play important roles in multiple
cytokine signaling involved in innate and adaptive
immunity.
Length = 283
Score = 31.0 bits (70), Expect = 0.37
Identities = 11/25 (44%), Positives = 14/25 (56%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKL 28
Y LM++CW A RP F L+ L
Sbjct: 254 YILMKNCWETEAKFRPTFRSLIPIL 278
>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase,
Csk homologous kinase. Protein Tyrosine Kinase (PTK)
family; Csk homologous kinase (Chk); catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Csk
subfamily kinases are cytoplasmic (or nonreceptor) tyr
kinases containing the Src homology domains, SH3 and
SH2, N-terminal to the catalytic tyr kinase domain. They
negatively regulate the activity of Src kinases that are
anchored to the plasma membrane. Chk is also referred to
as megakaryocyte-associated tyrosine kinase (Matk). To
inhibit Src kinases, Chk is translocated to the membrane
via binding to specific transmembrane proteins,
G-proteins, or adaptor proteins near the membrane. Chk
inhibit Src kinases using a noncatalytic mechanism by
simply binding to them. As a negative regulator of Src
kinases, Chk may play important roles in cell
proliferation, survival, and differentiation, and
consequently, in cancer development and progression. Chk
is expressed in brain and hematopoietic cells. Studies
in mice reveal that Chk is not functionally redundant
with Csk and that it plays an important role as a
regulator of immune responses. Chk also plays a role in
neural differentiation in a manner independent of Src by
enhancing Mapk activation via Ras-mediated signaling.
Length = 254
Score = 30.7 bits (69), Expect = 0.38
Identities = 11/27 (40%), Positives = 15/27 (55%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDR 30
Y LM CW +RP F +L KL++
Sbjct: 227 YVLMTSCWETEPKKRPSFHKLREKLEK 253
>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine
Kinases, Platelet Derived Growth Factor Receptors.
Protein Tyrosine Kinase (PTK) family; Platelet Derived
Growth Factor Receptor (PDGFR) subfamily; catalytic (c)
domain. The PDGFR subfamily consists of PDGFR alpha,
PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar
proteins. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
PDGFR subfamily members are receptor tyr kinases (RTKs)
containing an extracellular ligand-binding region with
five immunoglobulin-like domains, a transmembrane
segment, and an intracellular catalytic domain. PDGFR
kinase domains are autoinhibited by their juxtamembrane
regions containing tyr residues. The binding to their
ligands leads to receptor dimerization, trans
phosphorylation and activation, and intracellular
signaling. PDGFR subfamily receptors are important in
the development of a variety of cells. PDGFRs are
expressed in a many cells including fibroblasts,
neurons, endometrial cells, mammary epithelial cells,
and vascular smooth muscle cells. PDGFR signaling is
critical in normal embryonic development, angiogenesis,
and wound healing. PDGFRs transduce mitogenic signals
for connective tissue cells and are important for cell
shape and motility. Kit is important in the development
of melanocytes, germ cells, mast cells, hematopoietic
stem cells, the interstitial cells of Cajal, and the
pacemaker cells of the GI tract. CSF-1R signaling is
critical in the regulation of macrophages and
osteoclasts. Mammalian FLT3 plays an important role in
the survival, proliferation, and differentiation of stem
cells.
Length = 302
Score = 30.9 bits (70), Expect = 0.40
Identities = 10/29 (34%), Positives = 17/29 (58%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
Y++M+ CW +RP F Q+V + + L
Sbjct: 274 YDIMKTCWDADPLKRPTFKQIVQLIGKQL 302
>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine
Kinases, Bruton's tyrosine kinase and Bone marrow kinase
on the X chromosome. Protein Tyrosine Kinase (PTK)
family; Bruton's tyrosine kinase (Btk) and Bone marrow
kinase on the X chromosome (Bmx); catalytic (c) domain.
The PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Btk and
Bmx (also named Etk) are members of the Tec subfamily of
proteins, which are cytoplasmic (or nonreceptor) tyr
kinases with similarity to Src kinases in that they
contain Src homology protein interaction domains (SH3,
SH2) N-terminal to the catalytic tyr kinase domain.
Unlike Src kinases, most Tec subfamily members (except
Rlk) also contain an N-terminal pleckstrin homology (PH)
domain, which binds the products of PI3K and allows
membrane recruitment and activation. In addition, Btk
contains the Tec homology (TH) domain with proline-rich
and zinc-binding regions. Tec kinases are expressed
mainly by haematopoietic cells. Btk is expressed in
B-cells, and a variety of myeloid cells including mast
cells, platelets, neutrophils, and dendrictic cells. It
interacts with a variety of partners, from cytosolic
proteins to nuclear transcription factors, suggesting a
diversity of functions. Stimulation of a diverse array
of cell surface receptors, including antigen engagement
of the B-cell receptor (BCR), leads to PH-mediated
membrane translocation of Btk and subsequent
phosphorylation by Src kinase and activation. Btk plays
an important role in the life cycle of B-cells including
their development, differentiation, proliferation,
survival, and apoptosis. Mutations in Btk cause the
primary immunodeficiency disease, X-linked
agammaglobulinaemia (XLA) in humans. Bmx is primarily
expressed in bone marrow and the arterial endothelium,
and plays an important role in ischemia-induced
angiogenesis. It facilitates arterial growth, capillary
formation, vessel maturation, and bone marrow-derived
endothelial progenitor cell mobilization.
Length = 256
Score = 30.6 bits (69), Expect = 0.46
Identities = 12/25 (48%), Positives = 15/25 (60%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKL 28
Y +M CW A ERP F QL+S +
Sbjct: 231 YAIMYSCWHEKAEERPTFQQLLSSI 255
>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein
Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family;
Fes subfamily; catalytic (c) domain. Fes subfamily
members include Fes (or Fps), Fer, and similar proteins.
The PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Fes
subfamily proteins are cytoplasmic (or nonreceptor) tyr
kinases containing an N-terminal region with FCH
(Fes/Fer/CIP4 homology) and coiled-coil domains,
followed by a SH2 domain, and a C-terminal catalytic
domain. The genes for Fes (feline sarcoma) and Fps
(Fujinami poultry sarcoma) were first isolated from
tumor-causing retroviruses. The viral oncogenes encode
chimeric Fes proteins consisting of Gag sequences at the
N-termini, resulting in unregulated tyr kinase activity.
Fes and Fer kinases play roles in haematopoiesis,
inflammation and immunity, growth factor signaling,
cytoskeletal regulation, cell migration and adhesion,
and the regulation of cell-cell interactions. Fes and
Fer show redundancy in their biological functions.
Length = 251
Score = 30.5 bits (69), Expect = 0.47
Identities = 10/26 (38%), Positives = 15/26 (57%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLD 29
Y LM CW+Y RP F ++ ++L
Sbjct: 225 YRLMLQCWAYDPENRPSFSEIYNELQ 250
>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the
Protein Tyrosine Kinases, Janus kinases. Protein
Tyrosine Kinase (PTK) family; Janus kinase (Jak)
subfamily; pseudokinase domain (repeat1). The Jak
subfamily is composed of Jak1, Jak2, Jak3, TYK2, and
similar proteins. The PTKc (catalytic domain) family to
which this subfamily belongs, is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
Jak subfamily proteins are cytoplasmic (or nonreceptor)
tyr kinases containing an N-terminal FERM domain,
followed by a Src homology 2 (SH2) domain, a
pseudokinase domain, and a C-terminal catalytic tyr
kinase domain. The pseudokinase domain shows similarity
to tyr kinases but lacks crucial residues for catalytic
activity and ATP binding. It modulates the kinase
activity of the C-terminal catalytic domain. Most Jaks
are expressed in a wide variety of tissues, except for
Jak3, which is expressed only in hematopoietic cells.
Jaks are crucial for cytokine receptor signaling. They
are activated by autophosphorylation upon
cytokine-induced receptor aggregation, and subsequently
trigger downstream signaling events such as the
phosphorylation of signal transducers and activators of
transcription (STATs). Jaks are also involved in
regulating the surface expression of some cytokine
receptors. The Jak-STAT pathway is involved in many
biological processes including hematopoiesis,
immunoregulation, host defense, fertility, lactation,
growth, and embryogenesis.
Length = 259
Score = 30.5 bits (69), Expect = 0.49
Identities = 8/24 (33%), Positives = 14/24 (58%)
Query: 5 ELMRDCWSYVASERPEFIQLVSKL 28
L+ CW+Y ++RP F ++ L
Sbjct: 235 NLINQCWTYDPTKRPSFRAILRDL 258
>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine
Kinase, Discoidin Domain Receptor 1. Protein Tyrosine
Kinase (PTK) family; mammalian Discoidin Domain Receptor
1 (DDR1) and homologs; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. DDR1 is a
member of the DDR subfamily, which are receptor tyr
kinases (RTKs) containing an extracellular discoidin
homology domain, a transmembrane segment, an extended
juxtamembrane region, and an intracellular catalytic
domain. The binding of the ligand, collagen, to DDRs
results in a slow but sustained receptor activation.
DDR1 binds to all collagens tested to date (types I-IV).
It is widely expressed in many tissues. It is abundant
in the brain and is also found in keratinocytes, colonic
mucosa epithelium, lung epithelium, thyroid follicles,
and the islets of Langerhans. During embryonic
development, it is found in the developing
neuroectoderm. DDR1 is a key regulator of cell
morphogenesis, differentiation and proliferation. It is
important in the development of the mammary gland, the
vasculator and the kidney. DDR1 is also found in human
leukocytes, where it facilitates cell adhesion,
migration, maturation, and cytokine production.
Length = 304
Score = 30.3 bits (68), Expect = 0.53
Identities = 11/21 (52%), Positives = 12/21 (57%)
Query: 4 YELMRDCWSYVASERPEFIQL 24
YELM CWS ERP F +
Sbjct: 278 YELMLQCWSRDCRERPSFSDI 298
>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine
Kinase, C-ros. Protein Tyrosine Kinases (PTK) family;
C-ros and Drosophila Sevenless proteins; catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. The
proto-oncogene c-ros encodes an orphan receptor tyr
kinase (RTK) with an unknown ligand. RTKs contain an
extracellular ligand-binding domain, a transmembrane
region, and an intracellular tyr kinase domain. RTKs are
usually activated through ligand binding, which causes
dimerization and autophosphorylation of the
intracellular tyr kinase catalytic domain. C-ros is
expressed in embryonic cells of the kidney, intestine
and lung, but disappears soon after birth. It persists
only in the adult epididymis. Male mice bearing inactive
mutations of c-ros lack the initial segment of the
epididymis and are infertile. The Drosophila protein,
Sevenless, is required for the specification of the R7
photoreceptor cell during eye development.
Length = 269
Score = 30.2 bits (68), Expect = 0.61
Identities = 11/25 (44%), Positives = 16/25 (64%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKL 28
Y+LM +CW+ SERP F ++ L
Sbjct: 243 YQLMTNCWAQDPSERPTFDRIQEIL 267
>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase,
Kit. Protein Tyrosine Kinase (PTK) family; Kit (or
c-Kit); catalytic (c) domain. The PTKc family is part of
a larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Kit is a member of the
Platelet Derived Growth Factor Receptor (PDGFR)
subfamily of proteins, which are receptor tyr kinases
(RTKs) containing an extracellular ligand-binding region
with five immunoglobulin-like domains, a transmembrane
segment, and an intracellular catalytic domain. The
binding of Kit to its ligand, the stem-cell factor
(SCF), leads to receptor dimerization, trans
phosphorylation and activation, and intracellular
signaling. Kit is important in the development of
melanocytes, germ cells, mast cells, hematopoietic stem
cells, the interstitial cells of Cajal, and the
pacemaker cells of the GI tract. Kit signaling is
involved in major cellular functions including cell
survival, proliferation, differentiation, adhesion, and
chemotaxis. Mutations in Kit, which result in
constitutive ligand-independent activation, are found in
human cancers such as gastrointestinal stromal tumor
(GIST) and testicular germ cell tumor (TGCT). The
aberrant expression of Kit and/or SCF is associated with
other tumor types such as systemic mastocytosis and
cancers of the breast, neurons, lung, prostate, colon,
and rectum. Although the structure of the human Kit
catalytic domain is known, it is excluded from this
specific alignment model because it contains a deletion
in its sequence.
Length = 375
Score = 30.2 bits (68), Expect = 0.67
Identities = 10/29 (34%), Positives = 18/29 (62%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
Y++M+ CW +RP F Q+V +++ L
Sbjct: 347 YDIMKSCWDADPLKRPTFKQIVQLIEQQL 375
>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase,
REarranged during Transfection protein. Protein
Tyrosine Kinase (PTK) family; RET (REarranged during
Transfection) protein; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. RET is a
receptor tyr kinase (RTK) containing an extracellular
region with four cadherin-like repeats, a
calcium-binding site, and a cysteine-rich domain, a
transmembrane segment, and an intracellular catalytic
domain. It is part of a multisubunit complex that binds
glial-derived neurotropic factor (GDNF) family ligands
(GFLs) including GDNF, neurturin, artemin, and
persephin. GFLs bind RET along with four GPI-anchored
coreceptors, bringing two RET molecules together,
leading to autophosphorylation, activation, and
intracellular signaling. RET is essential for the
development of the sympathetic, parasympathetic and
enteric nervous systems, and the kidney. RET disruption
by germline mutations causes diseases in humans
including congenital aganglionosis of the
gastrointestinal tract (Hirschsprung's disease) and
three related inherited cancers: multiple endocrine
neoplasia type 2A (MEN2A), MEN2B, and familial medullary
thyroid carcinoma (FMTC).
Length = 290
Score = 29.9 bits (67), Expect = 0.76
Identities = 9/29 (31%), Positives = 16/29 (55%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
Y LM CW +RP F + +L++++
Sbjct: 259 YNLMLTCWKQEPDKRPTFADISKELEKMM 287
>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine
Kinase, Colony-Stimulating Factor-1 Receptor. Protein
Tyrosine Kinase (PTK) family; Colony-Stimulating
Factor-1 Receptor (CSF-1R); catalytic (c) domain. The
PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. CSF-1R,
also called c-Fms, is a member of the Platelet Derived
Growth Factor Receptor (PDGFR) subfamily of proteins,
which are receptor tyr kinases (RTKs) containing an
extracellular ligand-binding region with five
immunoglobulin-like domains, a transmembrane segment,
and an intracellular catalytic domain. The binding of
CSF-1R to its ligand, CSF-1, leads to receptor
dimerization, trans phosphorylation and activation, and
intracellular signaling. CSF-1R signaling is critical in
the regulation of macrophages and osteoclasts. It leads
to increases in gene transcription and protein
translation, and induces cytoskeletal remodeling. CSF-1R
signaling leads to a variety of cellular responses
including survival, proliferation, and differentiation
of target cells. It plays an important role in innate
immunity, tissue development and function, and the
pathogenesis of some diseases including atherosclerosis
and cancer. CSF-1R signaling is also implicated in
mammary gland development during pregnancy and
lactation. Aberrant CSF-1/CSF-1R expression correlates
with tumor cell invasiveness, poor clinical prognosis,
and bone metastasis in breast cancer. Although the
structure of the human CSF-1R catalytic domain is known,
it is excluded from this specific alignment model
because it contains a deletion in its sequence.
Length = 374
Score = 29.8 bits (67), Expect = 0.84
Identities = 11/29 (37%), Positives = 17/29 (58%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
Y +M+ CW+ +ERP F Q+ + R L
Sbjct: 345 YSIMKMCWNLEPTERPTFSQISQLIQRQL 373
>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein
Tyrosine Kinase, Janus kinase 1. Protein Tyrosine
Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic
(c) domain (repeat 2). The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Jak1 is a member of the
Janus kinase (Jak) subfamily of proteins, which are
cytoplasmic (or nonreceptor) tyr kinases containing an
N-terminal FERM domain, followed by a Src homology 2
(SH2) domain, a pseudokinase domain, and a C-terminal
tyr kinase domain. Jaks are crucial for cytokine
receptor signaling. They are activated by
autophosphorylation upon cytokine-induced receptor
aggregation, and subsequently trigger downstream
signaling events such as the phosphorylation of signal
transducers and activators of transcription (STATs).
Jak1 is widely expressed in many tissues. Many cytokines
are dependent on Jak1 for signaling, including those
that use the shared receptor subunits common gamma chain
(IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6,
IL-11, oncostatin M, G-CSF, and IFNs, among others). The
many varied interactions of Jak1 and its ubiquitous
expression suggest many biological roles. Jak1 is
important in neurological development, as well as in
lymphoid development and function. It also plays a role
in the pathophysiology of cardiac hypertrophy and heart
failure. A mutation in the ATP-binding site of Jak1 was
identified in a human uterine leiomyosarcoma cell line,
resulting in defective cytokine induction and antigen
presentation, thus allowing the tumor to evade the
immune system.
Length = 284
Score = 29.9 bits (67), Expect = 0.92
Identities = 12/29 (41%), Positives = 17/29 (58%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
Y+LMR CW + S+R F L+ + IL
Sbjct: 256 YQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284
>gnl|CDD|153137 cd06269, PBP1_glutamate_receptors_like, Family C G-protein couples
receptors (GPCRs), membrane bound guanylyl cyclases such
as the family of natriuretic peptide receptors (NPRs),
and the N-terminal leucine/isoleucine/valine- binding
protein (LIVBP)-like domain of the ionotropic glutamate
receptors. This CD represents the ligand-binding domain
of the family C G-protein couples receptors (GPCRs),
membrane bound guanylyl cyclases such as the family of
natriuretic peptide receptors (NPRs), and the N-terminal
leucine/isoleucine/valine- binding protein (LIVBP)-like
domain of the ionotropic glutamate receptors, all of
which are structurally similar and related to the
periplasmic-binding fold type I family. The family C
GPCRs consist of metabotropic glutamate receptor (mGluR)
receptors, a calcium-sensing receptor (CaSR),
gamma-aminobutyric receptors (GABAb), the promiscuous
L-alpha-amino acid receptor GPR6A, families of taste and
pheromone receptors, and orphan receptors. Truncated
splicing variants of the orphan receptors are not
included in this CD. The family C GPCRs are activated by
endogenous agonists such as amino acids, ions, and sugar
based molecules. Their amino terminal ligand-binding
region is homologous to the bacterial
leucine-isoleucine-valine binding protein (LIVBP) and a
leucine binding protein (LBP). The ionotropic glutamate
receptors (iGluRs) have an integral ion channel and are
subdivided into three major groups based on their
pharmacology and structural similarities: NMDA
receptors, AMPA receptors, and kainate receptors. The
family of membrane bound guanylyl cyclases is further
divided into three subfamilies: the ANP receptor
(GC-A)/C-type natriuretic peptide receptor (GC-B), the
heat-stable enterotoxin receptor (GC-C)/sensory organ
specific membrane GCs such as retinal receptors (GC-E,
GC-F), and olfactory receptors (GC-D and GC-G).
Length = 298
Score = 29.4 bits (66), Expect = 1.2
Identities = 15/119 (12%), Positives = 36/119 (30%), Gaps = 7/119 (5%)
Query: 83 DGEQMKYLIQVNPPGDILPEVIRAIILMQNITDAGILFDD-----SFIFDHKYKSLLQNI 137
D EQ ++ P + I ++ T G+++ D + + + I
Sbjct: 110 DKEQFPSFLRTVPSDSSQAQAIVDLLKHFGWTWVGLVYSDDDYGRRLLELLEEELEKNGI 169
Query: 138 PTRHIIAPVEDSRSVKRQLFRFKDLDIVNYFIL-GRLQTIKMILDSANVNKFFGRKFAW 195
+ + + S ++R L K ++ + +L+ A
Sbjct: 170 CVAFVESIPDGSEDIRRLLKELKSST-ARVIVVFSSEEDALRLLEEAVELGMMTGYHWI 227
>gnl|CDD|240521 cd13394, Syo1_like, Fungal symportin 1 (syo1) and similar proteins.
This family of eukaryotic proteins includes
Saccharomyces cerevisiae Ydl063c and Chaetomium
thermophilum Syo1, which mediate the co-import of two
ribosomal proteins, Rpl5 and Rpl11 (which both interact
with 5S rRNA) into the nucleus. Import precedes their
association with rRNA and subsequent ribosome assembly
in the nucleolus. The primary structure of syo1 is a
mixture of Armadillo- (ARM, N-terminal part of syo1) and
HEAT-repeats (C-terminal part of syo1).
Length = 597
Score = 29.2 bits (66), Expect = 1.4
Identities = 15/88 (17%), Positives = 27/88 (30%), Gaps = 6/88 (6%)
Query: 23 QLVSKLDRILTVTANEYLG------QEYLELEAPLLDTPPSSEDESNDDEETCAYLLESV 76
L+ L IL++ A E L + + + E++ +D+ S
Sbjct: 281 ILLPILSAILSILALEILANICKELDKKDDEAMEDEQSDEDEEEDEDDEASETLVPELSP 340
Query: 77 IRISNLDGEQMKYLIQVNPPGDILPEVI 104
+ IS + LI P
Sbjct: 341 LEISLDLLTALLELIAPTPESVEPILPS 368
>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase,
Interleukin-2-inducible T-cell Kinase. Protein Tyrosine
Kinase (PTK) family; Interleukin-2 (IL-2)-inducible
T-cell kinase (Itk); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Itk (also
known as Tsk or Emt) is a member of the Tec subfamily of
proteins, which are cytoplasmic (or nonreceptor) tyr
kinases with similarity to Src kinases in that they
contain Src homology protein interaction domains (SH3,
SH2) N-terminal to the catalytic tyr kinase domain.
Unlike Src kinases, most Tec subfamily members (except
Rlk) also contain an N-terminal pleckstrin homology (PH)
domain, which binds the products of PI3K and allows
membrane recruitment and activation. In addition, Itk
contains the Tec homology (TH) domain containing one
proline-rich region and a zinc-binding region. Tec
kinases are expressed mainly by haematopoietic cells.
Itk is expressed in T-cells and mast cells, and is
important in their development and differentiation. Of
the three Tec kinases expressed in T-cells, Itk plays
the predominant role in T-cell receptor (TCR) signaling.
It is activated by phosphorylation upon TCR crosslinking
and is involved in the pathway resulting in
phospholipase C-gamma1 activation and actin
polymerization. It also plays a role in the downstream
signaling of the T-cell costimulatory receptor CD28, the
T-cell surface receptor CD2, and the chemokine receptor
CXCR4. In addition, Itk is crucial for the development
of T-helper(Th)2 effector responses.
Length = 256
Score = 28.8 bits (64), Expect = 1.8
Identities = 12/27 (44%), Positives = 16/27 (59%)
Query: 2 SSYELMRDCWSYVASERPEFIQLVSKL 28
S YELM+ CW +RP F L+ +L
Sbjct: 229 SVYELMQHCWKERPEDRPSFSLLLHQL 255
>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine
Kinase, Discoidin Domain Receptor 2. Protein Tyrosine
Kinase (PTK) family; mammalian Discoidin Domain Receptor
2 (DDR2) and homologs; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. DDR2 is a
member of the DDR subfamily, which are receptor tyr
kinases (RTKs) containing an extracellular discoidin
homology domain, a transmembrane segment, an extended
juxtamembrane region, and an intracellular catalytic
domain. The binding of the ligand, collagen, to DDRs
results in a slow but sustained receptor activation.
DDR2 binds mostly to fibrillar collagens. More recently,
it has been reported to also bind collagen X. DDR2 is
widely expressed in many tissues with the highest levels
found in skeletal muscle, skin, kidney and lung. It is
important in cell proliferation and development. Mice,
with a deletion of DDR2, suffer from dwarfism and
delayed healing of epidermal wounds. DDR2 also
contributes to collagen (type I) regulation by
inhibiting fibrillogenesis and altering the morphology
of collagen fibers. It is also expressed in immature
dendritic cells (DCs), where it plays a role in DC
activation and function.
Length = 296
Score = 28.7 bits (64), Expect = 1.8
Identities = 12/27 (44%), Positives = 16/27 (59%)
Query: 2 SSYELMRDCWSYVASERPEFIQLVSKL 28
S Y+LM CW A ERP F ++ + L
Sbjct: 268 SLYKLMLSCWRRNAKERPSFQEIHATL 294
>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine
Kinases, Receptor tyrosine kinase-like Orphan Receptors.
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine
kinase-like Orphan Receptor (Ror) subfamily; catalytic
(c) domain. The Ror subfamily consists of Ror1, Ror2,
and similar proteins. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Ror proteins are orphan
receptor tyr kinases (RTKs) containing an extracellular
region with immunoglobulin-like, cysteine-rich, and
kringle domains, a transmembrane segment, and an
intracellular catalytic domain. Ror RTKs are unrelated
to the nuclear receptor subfamily called
retinoid-related orphan receptors (RORs). RTKs are
usually activated through ligand binding, which causes
dimerization and autophosphorylation of the
intracellular tyr kinase catalytic domain. Ror kinases
are expressed in many tissues during development. They
play important roles in bone and heart formation.
Mutations in human Ror2 result in two different bone
development genetic disorders, recessive Robinow
syndrome and brachydactyly type B. Drosophila Ror is
expressed only in the developing nervous system during
neurite outgrowth and neuronal differentiation,
suggesting a role for Drosophila Ror in neural
development. More recently, mouse Ror1 and Ror2 have
also been found to play an important role in regulating
neurite growth in central neurons. Ror1 and Ror2 are
believed to have some overlapping and redundant
functions.
Length = 283
Score = 28.6 bits (64), Expect = 2.0
Identities = 9/25 (36%), Positives = 16/25 (64%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKL 28
Y LM +CW+ + + RP F + ++L
Sbjct: 256 YALMIECWNEIPARRPRFKDIHTRL 280
>gnl|CDD|238312 cd00557, Translocase_SecB, Preprotein translocase subunit SecB.
SecB is a cytoplasmic component of the multisubunit
membrane-bound enzyme termed Sec protein translocase,
which is the main constituent of the General Secretory
(type II) Pathway involved in translocation of nascent
polypeptides across the cytoplasmic membrane. SecB has
been shown to function as export-specific molecular
chaperone that selectively binds preproteins, maintains
them in a translocation competent state and delivers
them to SecA, the membrane-bound ATPase, that drives the
translocation reaction. In solution, SecB exists as
homotetramer, which is organized as a dimer of dimers.
Length = 131
Score = 27.9 bits (62), Expect = 2.2
Identities = 11/52 (21%), Positives = 24/52 (46%), Gaps = 6/52 (11%)
Query: 61 ESNDDEETCAYLLE----SVIRISNLDGEQMKYLIQVNPPGDILPEVIRAII 108
+ ++ A+ E V I ++ +QM + +++N P + P R +I
Sbjct: 57 AKLEFAKS-AFYCEVKQAGVFEIIGIEIDQMAHCLEINCPAILFPYA-RELI 106
>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase,
Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Fer kinase is a member
of the Fes subfamily of proteins which are cytoplasmic
(or nonreceptor) tyr kinases containing an N-terminal
region with FCH (Fes/Fer/CIP4 homology) and coiled-coil
domains, followed by a SH2 domain, and a C-terminal
catalytic domain. Fer kinase is expressed in a wide
variety of tissues, and is found to reside in both the
cytoplasm and the nucleus. It plays important roles in
neuronal polarization and neurite development,
cytoskeletal reorganization, cell migration, growth
factor signaling, and the regulation of cell-cell
interactions mediated by adherens junctions and focal
adhesions. Fer kinase also regulates cell cycle
progression in malignant cells.
Length = 250
Score = 28.4 bits (63), Expect = 2.2
Identities = 10/25 (40%), Positives = 16/25 (64%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKL 28
Y++M+ CW Y RP+F +L +L
Sbjct: 224 YKVMQRCWDYKPENRPKFSELQKEL 248
>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine
Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK)
family; Insulin Receptor (InsR); catalytic (c) domain.
The PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. InsR is a
receptor tyr kinase (RTK) that is composed of two
alphabeta heterodimers. Binding of the insulin ligand to
the extracellular alpha subunit activates the
intracellular tyr kinase domain of the transmembrane
beta subunit. Receptor activation leads to
autophosphorylation, stimulating downstream kinase
activities, which initiate signaling cascades and
biological function. InsR signaling plays an important
role in many cellular processes including glucose
homeostasis, glycogen synthesis, lipid and protein
metabolism, ion and amino acid transport, cell cycle and
proliferation, cell differentiation, gene transcription,
and nitric oxide synthesis. Insulin resistance, caused
by abnormalities in InsR signaling, has been described
in diabetes, hypertension, cardiovascular disease,
metabolic syndrome, heart failure, and female
infertility.
Length = 288
Score = 28.4 bits (63), Expect = 2.7
Identities = 10/25 (40%), Positives = 16/25 (64%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKL 28
+LMR CW + RP F+++V+ L
Sbjct: 251 TDLMRMCWQFNPKMRPTFLEIVNLL 275
>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth
Factor Receptor-like Protein Tyrosine Kinases. Protein
Tyrosine Kinase (PTK) family; Epidermal Growth Factor
Receptor (EGFR) subfamily; catalytic (c) domain. EGFR
(HER, ErbB) subfamily members include EGFR (HER1,
ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and
similar proteins. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
The EGFR proteins are receptor tyr kinases (RTKs)
containing an extracellular EGF-related ligand-binding
region, a transmembrane helix, and a cytoplasmic region
with a tyr kinase domain and a regulatory C-terminal
tail. Unlike other tyr kinases, phosphorylation of the
activation loop of EGFR proteins is not critical to
their activation. Instead, they are activated by
ligand-induced dimerization, resulting in the
phosphorylation of tyr residues in the C-terminal tail,
which serve as binding sites for downstream signaling
molecules. Collectively, they can recognize a variety of
ligands including EGF, TGFalpha, and neuregulins, among
others. All four subfamily members can form homo- or
heterodimers. HER3 contains an impaired kinase domain
and depends on its heterodimerization partner for
activation. EGFR subfamily members are involved in
signaling pathways leading to a broad range of cellular
responses including cell proliferation, differentiation,
migration, growth inhibition, and apoptosis. Gain of
function alterations, through their overexpression,
deletions, or point mutations in their kinase domains,
have been implicated in various cancers. These receptors
are targets of many small molecule inhibitors and
monoclonal antibodies used in cancer therapy.
Length = 279
Score = 28.1 bits (63), Expect = 2.7
Identities = 8/29 (27%), Positives = 16/29 (55%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
Y ++ CW A RP F +L+++ ++
Sbjct: 241 YMVLVKCWMIDAESRPTFKELINEFSKMA 269
>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine
Kinases, Lymphocyte-specific kinase and Blk. Protein
Tyrosine Kinase (PTK) family; Lck and Blk kinases;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Lck (lymphocyte-specific
kinase) and Blk are members of the Src subfamily of
proteins, which are cytoplasmic (or non-receptor) tyr
kinases. Src kinases contain an N-terminal SH4 domain
with a myristoylation site, followed by SH3 and SH2
domains, a tyr kinase domain, and a regulatory
C-terminal region containing a conserved tyr. They are
activated by autophosphorylation at the tyr kinase
domain, but are negatively regulated by phosphorylation
at the C-terminal tyr by Csk (C-terminal Src Kinase).
Src proteins are involved in signaling pathways that
regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. Lck is expressed in T-cells and natural
killer (NK) cells. It plays a critical role in T-cell
maturation, activation, and T-cell receptor (TCR)
signaling. Lck phosphorylates ITAM (immunoreceptor tyr
activation motif) sequences on several subunits of TCRs,
leading to the activation of different second messenger
cascades. Phosphorylated ITAMs serve as binding sites
for other signaling factor such as Syk and ZAP-70,
leading to their activation and propagation of
downstream events. In addition, Lck regulates
drug-induced apoptosis by interfering with the
mitochondrial death pathway. The apototic role of Lck is
independent of its primary function in T-cell signaling.
Blk is expressed specifically in B-cells. It is involved
in pre-BCR (B-cell receptor) signaling.
Length = 260
Score = 28.3 bits (63), Expect = 3.0
Identities = 14/26 (53%), Positives = 15/26 (57%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLD 29
YELMR CW ERP F L S L+
Sbjct: 233 YELMRLCWKEKPEERPTFEYLRSVLE 258
>gnl|CDD|215694 pfam00074, RnaseA, Pancreatic ribonuclease. Ribonucleases. Members
include pancreatic RNAase A and angiogenins. Structure
is an alpha+beta fold -- long curved beta sheet and
three helices.
Length = 120
Score = 27.3 bits (61), Expect = 3.3
Identities = 15/62 (24%), Positives = 23/62 (37%), Gaps = 8/62 (12%)
Query: 139 TRHIIAPVEDSRSV-------KRQLFRFKDLDIVNYFILGRLQTIKMILDSANVNKFFGR 191
+HI +P +S KR + + VN FI +K + + NV G
Sbjct: 10 RQHIDSPSTNSSPRYCNEMMRKRNMTTGRCKP-VNTFIHESFADVKAVCGNPNVTCKNGN 68
Query: 192 KF 193
K
Sbjct: 69 KN 70
>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase,
Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps)
kinase subfamily; catalytic (c) domain. The PTKc family
is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Fes
subfamily proteins are cytoplasmic (or nonreceptor) tyr
kinases containing an N-terminal region with FCH
(Fes/Fer/CIP4 homology) and coiled-coil domains,
followed by a SH2 domain, and a C-terminal catalytic
domain. The genes for Fes (feline sarcoma) and Fps
(Fujinami poultry sarcoma) were first isolated from
tumor-causing retroviruses. The viral oncogenes encode
chimeric Fes proteins consisting of Gag sequences at the
N-termini, resulting in unregulated tyr kinase activity.
Fes kinase is expressed in myeloid, vascular
endothelial, epithelial, and neuronal cells. It plays
important roles in cell growth and differentiation,
angiogenesis, inflammation and immunity, and
cytoskeletal regulation. A recent study implicates Fes
kinase as a tumor suppressor in colorectal cancer.
Length = 252
Score = 28.1 bits (62), Expect = 3.4
Identities = 9/18 (50%), Positives = 10/18 (55%)
Query: 4 YELMRDCWSYVASERPEF 21
Y LM CW Y +RP F
Sbjct: 226 YRLMERCWEYDPGQRPSF 243
>gnl|CDD|107361 cd06366, PBP1_GABAb_receptor, Ligand-binding domain of GABAb
receptors, which are metabotropic transmembrane
receptors for gamma-aminobutyric acid (GABA).
Ligand-binding domain of GABAb receptors, which are
metabotropic transmembrane receptors for
gamma-aminobutyric acid (GABA). GABA is the major
inhibitory neurotransmitter in the mammalian CNS and,
like glutamate and other transmitters, acts via both
ligand gated ion channels (GABAa receptors) and
G-protein coupled receptors (GABAb). GABAa receptors are
members of the ionotropic receptor superfamily which
includes alpha-adrenergic and glycine receptors. The
GABAb receptor is a member of a receptor superfamily
which includes the mGlu receptors. The GABAb receptor is
coupled to G alpha_i proteins, and activation causes a
decrease in calcium, an increase in potassium membrane
conductance, and inhibition of cAMP formation. The
response is thus inhibitory and leads to
hyperpolarization and decreased neurotransmitter
release, for example.
Length = 350
Score = 27.6 bits (62), Expect = 4.1
Identities = 13/64 (20%), Positives = 20/64 (31%), Gaps = 10/64 (15%)
Query: 137 IPTRHIIAPVEDSRSVKRQLFRFKDLD---IV--NYFILGRLQTIKMILDSANVNKFFGR 191
I R P + + L + K+ D IV L R + A G+
Sbjct: 166 ISYRAAFPPSANDDDITDALKKLKEKDSRVIVVHFSPDLAR-----RVFCEAYKLGMMGK 220
Query: 192 KFAW 195
+ W
Sbjct: 221 GYVW 224
>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine
Kinase, Receptor tyrosine kinase-like Orphan Receptor 2.
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine
kinase-like Orphan Receptor 2 (Ror2); catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Ror
proteins are orphan receptor tyr kinases (RTKs)
containing an extracellular region with
immunoglobulin-like, cysteine-rich, and kringle domains,
a transmembrane segment, and an intracellular catalytic
domain. Ror RTKs are unrelated to the nuclear receptor
subfamily called retinoid-related orphan receptors
(RORs). RTKs are usually activated through ligand
binding, which causes dimerization and
autophosphorylation of the intracellular tyr kinase
catalytic domain. Ror2 plays important roles in skeletal
and heart formation. Ror2-deficient mice show widespread
bone abnormalities, ventricular defects in the heart,
and respiratory dysfunction. Mutations in human Ror2
result in two different bone development genetic
disorders, recessive Robinow syndrome and brachydactyly
type B. Ror2 is also implicated in neural development.
Length = 283
Score = 27.7 bits (61), Expect = 4.3
Identities = 11/25 (44%), Positives = 15/25 (60%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKL 28
Y LM +CW+ S RP F + S+L
Sbjct: 256 YTLMLECWNEFPSRRPRFKDIHSRL 280
>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine
Kinase, Vascular Endothelial Growth Factor Receptor 3.
Protein Tyrosine Kinase (PTK) family; Vascular
Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic
(c) domain. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
VEGFR3 (or Flt4) is a member of the VEGFR subfamily of
proteins, which are receptor tyr kinases (RTKs)
containing an extracellular ligand-binding region with
seven immunoglobulin (Ig)-like domains, a transmembrane
segment, and an intracellular catalytic domain. In
VEGFR3, the fifth Ig-like domain is replaced by a
disulfide bridge. The binding of VEGFRs to their
ligands, the VEGFs, leads to receptor dimerization,
activation, and intracellular signaling. VEGFR3
preferentially binds the ligands VEGFC and VEGFD. VEGFR3
is essential for lymphatic endothelial cell (EC)
development and function. It has been shown to regulate
adaptive immunity during corneal transplantation. VEGFR3
is upregulated on blood vascular ECs in pathological
conditions such as vascular tumors and the periphery of
solid tumors. It plays a role in cancer progression and
lymph node metastasis. Missense mutations in the VEGFR3
gene are associated with primary human lymphedema.
Length = 338
Score = 27.7 bits (61), Expect = 4.4
Identities = 12/29 (41%), Positives = 14/29 (48%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRIL 32
Y +M CW ERP F LV L +L
Sbjct: 307 YRIMLACWQGDPKERPTFSALVEILGDLL 335
>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine
Kinases, Tyrosine kinase expressed in hepatocellular
carcinoma and Resting lymphocyte kinase. Protein
Tyrosine Kinase (PTK) family; Tyrosine kinase expressed
in hepatocellular carcinoma (Tec) and Resting lymphocyte
kinase (Rlk); catalytic (c) domain. The PTKc family is
part of a larger superfamily, that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Tec and
Rlk (also named Txk) are members of the Tec subfamily of
proteins, which are cytoplasmic (or nonreceptor) tyr
kinases with similarity to Src kinases in that they
contain Src homology protein interaction domains (SH3,
SH2) N-terminal to the catalytic tyr kinase domain.
Unlike Src kinases, most Tec subfamily members (except
Rlk) also contain an N-terminal pleckstrin homology (PH)
domain, which binds the products of PI3K and allows
membrane recruitment and activation. Instead of PH, Rlk
contains an N-terminal cysteine-rich region. In addition
to PH, Tec also contains the Tec homology (TH) domain
with proline-rich and zinc-binding regions. Tec kinases
are expressed mainly by haematopoietic cells. Tec is
more widely-expressed than other Tec subfamily kinases.
It is found in endothelial cells, both B- and T-cells,
and a variety of myeloid cells including mast cells,
erythroid cells, platelets, macrophages and neutrophils.
Rlk is expressed in T-cells and mast cell lines. Tec and
Rlk are both key components of T-cell receptor (TCR)
signaling. They are important in TCR-stimulated
proliferation, IL-2 production and phopholipase C-gamma1
activation.
Length = 256
Score = 27.5 bits (61), Expect = 4.4
Identities = 10/29 (34%), Positives = 15/29 (51%)
Query: 1 MSSYELMRDCWSYVASERPEFIQLVSKLD 29
M+ YE+M CW RP F +L+ +
Sbjct: 228 MTVYEVMYSCWHEKPEGRPTFAELLRAIT 256
>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine
Kinase, HER4. Protein Tyrosine Kinase (PTK) family;
HER4 (ErbB4); catalytic (c) domain. The PTKc family is
part of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. HER4 is a
member of the EGFR (HER, ErbB) subfamily of proteins,
which are receptor tyr kinases (RTKs) containing an
extracellular EGF-related ligand-binding region, a
transmembrane helix, and a cytoplasmic region with a tyr
kinase domain and a regulatory C-terminal tail. Unlike
other tyr kinases, phosphorylation of the activation
loop of EGFR proteins is not critical to their
activation. Instead, they are activated by
ligand-induced dimerization, leading to the
phosphorylation of tyr residues in the C-terminal tail,
which serve as binding sites for downstream signaling
molecules. Ligands that bind HER4 fall into two groups,
the neuregulins (or heregulins) and some EGFR (HER1)
ligands including betacellulin, HBEGF, and epiregulin.
All four neuregulins (NRG1-4) interact with HER4. Upon
ligand binding, HER4 forms homo- or heterodimers with
other HER proteins. HER4 is essential in embryonic
development. It is implicated in mammary gland, cardiac,
and neural development. As a postsynaptic receptor of
NRG1, HER4 plays an important role in synaptic
plasticity and maturation. The impairment of NRG1/HER4
signaling may contribute to schizophrenia.
Length = 303
Score = 27.7 bits (61), Expect = 4.8
Identities = 15/50 (30%), Positives = 25/50 (50%), Gaps = 4/50 (8%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRILTVTANEYL---GQEYLELEAP 50
Y +M CW A RP+F +L ++ R + YL G + ++L +P
Sbjct: 241 YMVMVKCWMIDADSRPKFKELAAEFSR-MARDPQRYLVIQGDDRMKLPSP 289
>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase,
Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Yes (or c-Yes) is a
member of the Src subfamily of proteins, which are
cytoplasmic (or non-receptor) tyr kinases. Src kinases
contain an N-terminal SH4 domain with a myristoylation
site, followed by SH3 and SH2 domains, a tyr kinase
domain, and a regulatory C-terminal region containing a
conserved tyr. They are activated by autophosphorylation
at the tyr kinase domain, but are negatively regulated
by phosphorylation at the C-terminal tyr by Csk
(C-terminal Src Kinase). Src proteins are involved in
signaling pathways that regulate cytokine and growth
factor responses, cytoskeleton dynamics, cell
proliferation, survival, and differentiation. c-Yes
kinase is the cellular homolog of the oncogenic protein
(v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma
viruses. It displays functional overlap with other Src
subfamily members, particularly Src. It also shows some
unique functions such as binding to occludins,
transmembrane proteins that regulate extracellular
interactions in tight junctions. Yes also associates
with a number of proteins in different cell types that
Src does not interact with, like JAK2 and gp130 in
pre-adipocytes, and Pyk2 in treated pulmonary vein
endothelial cells. Although the biological function of
Yes remains unclear, it appears to have a role in
regulating cell-cell interactions and vesicle
trafficking in polarized cells.
Length = 260
Score = 27.3 bits (60), Expect = 4.9
Identities = 12/28 (42%), Positives = 16/28 (57%)
Query: 2 SSYELMRDCWSYVASERPEFIQLVSKLD 29
S +ELM+ CW ERP F + S L+
Sbjct: 231 SLHELMKLCWKKDPDERPTFEYIQSFLE 258
>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine
Kinase, Receptor tyrosine kinase-like Orphan Receptor 1.
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine
kinase-like Orphan Receptor 1 (Ror1); catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Ror
proteins are orphan receptor tyr kinases (RTKs)
containing an extracellular region with
immunoglobulin-like, cysteine-rich, and kringle domains,
a transmembrane segment, and an intracellular catalytic
domain. Ror RTKs are unrelated to the nuclear receptor
subfamily called retinoid-related orphan receptors
(RORs). RTKs are usually activated through ligand
binding, which causes dimerization and
autophosphorylation of the intracellular tyr kinase
catalytic domain. Ror kinases are expressed in many
tissues during development. Avian Ror1 was found to be
involved in late limb development. Studies in mice
reveal that Ror1 is important in the regulation of
neurite growth in central neurons, as well as in
respiratory development. Loss of Ror1 also enhances the
heart and skeletal abnormalities found in Ror2-deficient
mice.
Length = 283
Score = 27.3 bits (60), Expect = 5.0
Identities = 10/25 (40%), Positives = 14/25 (56%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKL 28
Y LM +CW S RP F + ++L
Sbjct: 256 YSLMTECWQEGPSRRPRFKDIHTRL 280
>gnl|CDD|217103 pfam02556, SecB, Preprotein translocase subunit SecB. This family
consists of preprotein translocase subunit SecB. SecB is
required for the normal export of envelope proteins out
of the cell cytoplasm.
Length = 147
Score = 26.7 bits (60), Expect = 5.2
Identities = 14/52 (26%), Positives = 26/52 (50%), Gaps = 6/52 (11%)
Query: 61 ESNDDEETCAYLLE----SVIRISNLDGEQMKYLIQVNPPGDILPEVIRAII 108
+ ++E+T A+L+E + I N+ EQ+ + + P + P R II
Sbjct: 67 TAKNEEKT-AFLVEVKQAGIFTIRNVPEEQLHPFLGIECPNILFPYA-REII 116
>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase,
Src. Protein Tyrosine Kinase (PTK) family; Src kinase;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Src (or c-Src) is a
cytoplasmic (or non-receptor) tyr kinase, containing an
N-terminal SH4 domain with a myristoylation site,
followed by SH3 and SH2 domains, a tyr kinase domain,
and a regulatory C-terminal region with a conserved tyr.
It is activated by autophosphorylation at the tyr kinase
domain, and is negatively regulated by phosphorylation
at the C-terminal tyr by Csk (C-terminal Src Kinase).
c-Src is the vertebrate homolog of the oncogenic protein
(v-Src) from Rous sarcoma virus. Together with other Src
subfamily proteins, it is involved in signaling pathways
that regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. Src also play a role in regulating cell
adhesion, invasion, and motility in cancer cells and
tumor vasculature, contributing to cancer progression
and metastasis. Elevated levels of Src kinase activity
have been reported in a variety of human cancers.
Several inhibitors of Src have been developed as
anti-cancer drugs. Src is also implicated in acute
inflammatory responses and osteoclast function.
Length = 262
Score = 27.3 bits (60), Expect = 5.6
Identities = 12/32 (37%), Positives = 16/32 (50%)
Query: 2 SSYELMRDCWSYVASERPEFIQLVSKLDRILT 33
S ++LM CW ERP F L + L+ T
Sbjct: 231 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 262
>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine
Kinase, HER2. Protein Tyrosine Kinase (PTK) family;
HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. HER2 is a
member of the EGFR (HER, ErbB) subfamily of proteins,
which are receptor tyr kinases (RTKs) containing an
extracellular EGF-related ligand-binding region, a
transmembrane helix, and a cytoplasmic region with a tyr
kinase domain and a regulatory C-terminal tail. Unlike
other tyr kinases, phosphorylation of the activation
loop of EGFR proteins is not critical to their
activation. Instead, they are activated by
ligand-induced dimerization, leading to the
phosphorylation of tyr residues in the C-terminal tail,
which serve as binding sites for downstream signaling
molecules. HER2 does not bind to any known EGFR
subfamily ligands, but contributes to the kinase
activity of all possible heterodimers. It acts as the
preferred partner with other ligand-bound EGFR proteins
and functions as a signal amplifier, with the HER2-HER3
heterodimer being the most potent pair in mitogenic
signaling. HER2 plays an important role in cell
development, proliferation, survival and motility.
Overexpression of HER2 results in its activation and
downstream signaling, even in the absence of ligand.
HER2 overexpression, mainly due to gene amplification,
has been shown in a variety of human cancers. Its role
in breast cancer is especially well-documented. HER2 is
up-regulated in about 25% of breast tumors and is
associated with increases in tumor aggressiveness,
recurrence and mortality. HER2 is a target for
monoclonal antibodies and small molecule inhibitors,
which are being developed as treatments for cancer. The
first humanized antibody approved for clinical use is
Trastuzumab (Herceptin), which is being used in
combination with other therapies to improve the survival
rates of patients with HER2-overexpressing breast
cancer.
Length = 279
Score = 27.3 bits (60), Expect = 5.9
Identities = 10/28 (35%), Positives = 15/28 (53%)
Query: 4 YELMRDCWSYVASERPEFIQLVSKLDRI 31
Y +M CW + RP F +LV + R+
Sbjct: 241 YMIMVKCWMIDSECRPRFRELVDEFSRM 268
>gnl|CDD|213561 TIGR00809, secB, protein-export chaperone SecB. This protein acts
as an export-specific cytosolic chaperone. It binds the
mature region of pre-proteins destined for secretion,
prevents aggregation, and delivers them to SecA. This
protein is tetrameric in E. coli. The archaeal
Methanococcus jannaschii homolog MJ0357 has been shown
(PMID:14985117) to share many properties, including
chaperone-like activity, and scores between trusted and
noise [Protein fate, Protein and peptide secretion and
trafficking].
Length = 140
Score = 26.7 bits (59), Expect = 6.0
Identities = 13/40 (32%), Positives = 20/40 (50%), Gaps = 4/40 (10%)
Query: 66 EETCAYLLE----SVIRISNLDGEQMKYLIQVNPPGDILP 101
EE A+L E V I ++ EQM + + V+ P + P
Sbjct: 65 EEYTAFLCEVKQAGVFNIIGIESEQMAHCLGVHCPNMLFP 104
>gnl|CDD|236460 PRK09300, PRK09300, tRNA splicing endonuclease; Reviewed.
Length = 330
Score = 27.2 bits (61), Expect = 6.7
Identities = 14/48 (29%), Positives = 23/48 (47%), Gaps = 7/48 (14%)
Query: 133 LLQNIPTRHIIAPVEDSRSV-------KRQLFRFKDLDIVNYFILGRL 173
L++ IP H +P + SR+V K+ +F D + Y + RL
Sbjct: 281 LVRVIPDDHEFSPRDLSRAVRLAHSVRKKMVFALIDDGGIRYLSIERL 328
>gnl|CDD|211418 cd11577, GH71, Glycoside hydrolase family 71. This family of
glycoside hydrolases 71 (following the CAZY
nomenclature) function as alpha-1,3-glucanases
(mutanases, EC 3.2.1.59). They appear to have an
endo-hydrolytic mode of enzymatic activity and bacterial
members are investigated as candidates for the
development of dental caries treatments.The member from
fission yeast, endo-alpha-1,3-glucanase Agn1p, plays a
vital role in daughter cell separation, while Agn2p has
been associated with endolysis of the ascus wall.
Length = 283
Score = 26.9 bits (60), Expect = 7.5
Identities = 6/25 (24%), Positives = 16/25 (64%)
Query: 2 SSYELMRDCWSYVASERPEFIQLVS 26
+L RD W + + +P+F+++++
Sbjct: 209 RGDDLWRDRWEQIIALQPDFVEIIT 233
>gnl|CDD|220086 pfam08982, DUF1857, Domain of unknown function (DUF1857). This
domain has no known function. It is found in various
hypothetical bacterial and fungal proteins.
Length = 147
Score = 26.1 bits (58), Expect = 8.5
Identities = 7/18 (38%), Positives = 13/18 (72%)
Query: 89 YLIQVNPPGDILPEVIRA 106
+L+ +N PG+ +P + RA
Sbjct: 4 HLVPINDPGNDVPVLTRA 21
>gnl|CDD|227688 COG5401, COG5401, Spore germination protein [General function
prediction only].
Length = 250
Score = 26.7 bits (59), Expect = 9.1
Identities = 13/62 (20%), Positives = 22/62 (35%), Gaps = 9/62 (14%)
Query: 48 EAPLLDTPPSSEDESNDDEETCAYLLESVIRISNLDGEQMK-YLIQVNPPGDILPEVIRA 106
AP+ TP S LE G+ + Y + V+P G + +V++
Sbjct: 81 NAPVNGTPIPSR---KLGVN-----LEPGQPNDAQPGKAITLYFLAVDPDGYFVRQVVKR 132
Query: 107 II 108
Sbjct: 133 AN 134
Database: CDD.v3.10
Posted date: Mar 20, 2013 7:55 AM
Number of letters in database: 10,937,602
Number of sequences in database: 44,354
Lambda K H
0.322 0.139 0.401
Gapped
Lambda K H
0.267 0.0807 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 10,505,616
Number of extensions: 1013320
Number of successful extensions: 932
Number of sequences better than 10.0: 1
Number of HSP's gapped: 929
Number of HSP's successfully gapped: 102
Length of query: 202
Length of database: 10,937,602
Length adjustment: 92
Effective length of query: 110
Effective length of database: 6,857,034
Effective search space: 754273740
Effective search space used: 754273740
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 56 (25.2 bits)